NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|1002351797]
View 

Chain A, Spike glycoprotein,Foldon chimera

Protein Classification

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
CoV_Spike_S1-S2_S2 super family cl40439
S1/S2 cleavage region and the S2 fusion subunit of coronavirus spike (S) proteins; This model ...
611-1272 0e+00

S1/S2 cleavage region and the S2 fusion subunit of coronavirus spike (S) proteins; This model represents the S1/S2 cleavage region and the S2 subunit of the spike (S) glycoprotein from coronavirus (CoVs), including three highly pathogenic human CoVs, Middle East respiratory syndrome coronavirus (MERS-CoV), Severe acute respiratory syndrome (SARS) coronavirus (SARS-CoV), and SARS coronavirus 2 (SARS-CoV-2), also known as a 2019 novel coronavirus (2019-nCoV). The CoV S protein is an envelope glycoprotein that plays a very important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains the coronavirus fusion machinery and is primarily alpha-helical. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-terminal domain (C-domain). S1 C-domain also contains two subdomains (SD-1 and SD-2), which connect S1 and S2. Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBD of mouse hepatitis virus (MHV) is located at the NTD, most CoVs, including SARS-CoV-2, SARS-CoV, and MERS-CoV use the C-domain to bind their receptors. The S2 subunit comprises the fusion peptide (FP), a second proteolytic site (S2'), followed by an internal fusion peptide (IFP), and two heptad-repeat domains (HR1 and HR2) preceding the transmembrane domain (TM). After binding of the S1 subunit RBD on the virion to its receptor on the target cell, the HR1 and HR2 domains interact with each other to form a six-helix bundle (6-HB) fusion core, bringing viral and cellular membranes into close proximity for fusion and infection. In order to catalyze the membrane fusion reaction, CoV S needs to be primed through cleavage at the S1/S2 and S2' sites. Notably, SARS-CoV-2 has a functional polybasic (furin) cleavage site through the insertion of PRRAR*SV (* indicates the cleavage site) at the S1/S2 interface, which is absent in SARS-CoV and other SARS-related CoVs. The S1/S2 cleavage region and the S2 fusion subunit play an essential role in viral entry by initiating fusion of the viral and cellular membranes.


The actual alignment was detected with superfamily member cd22380:

Pssm-ID: 424070 [Multi-domain]  Cd Length: 663  Bit Score: 1231.18  E-value: 0e+00
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  611 LYGITGQGIFKEVSAAYYNNWQNLLYDSNGNIIGFKDFLTNKTYTILPCYSGRVSAAFYQNSSSPALLYRNLKCSYVLNN 690
Cdd:cd22380      1 LYGITGQGIFKEVNADYYNSWQNLLYDSNGNLYGFRDYLTNKTYMIRSCYSGRVSAAFHANASEPALLYRNLKCSYVFNN 80
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  691 ISF--ISQPFYFDSYLGCVLNAVNLTSYSVSSCDLRMGSGFCIDYalPSSGGSGSGISSPYRFVTFEPFNVSFVNDSVET 768
Cdd:cd22380     81 TISreEQPLNYFDSYLGCVVNADNSTSSAVQTCDLRMGSGYCVDY--STSRRSRRSISTGYRFTTFEPFTVNLVNDSVEP 158
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  769 VGGLFEIQIPTNFTIAGHEEFIQTSSPKVTIDCSAFVCSNYAACHDLLSEYGTFCDNINSILNEVNDLLDITQLQVANAL 848
Cdd:cd22380    159 VGGLYEIQIPTNFTIGNHEEFIQTSSPKVTIDCAAFVCGDYAACRQQLVEYGSFCDNINAILNEVNELLDTTQLQVANSL 238
                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  849 MQGVTLSSNLNTNLHSDVDNIDFKSLLGCLGSQCG-SSSRSLLEDLLFNKVKLSDVGFVEAYNNCTGGSEIRDLLCVQSF 927
Cdd:cd22380    239 MQGVTLSSRLKDGINFNVDDINFSPVLGCLGSDCNaASSRSAIEDLLFDKVKLSDVGFVEAYNNCTGGAEIRDLLCVQSF 318
                          330       340       350       360       370       380       390       400
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  928 NGIKVLPPILSETQISGYTTAATVAAMFPPWSAAAGVPFSLNVQYRINGLGVTMDVLNKNQKLIANAFNKALLSIQNGFT 1007
Cdd:cd22380    319 NGIKVLPPVLSENQISGYTTAATAASLFPPWSAAAGVPFSLNVQYRINGLGVTMDVLSQNQKLIANAFNNALGAIQEGFD 398
                          410       420       430       440       450       460       470       480
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797 1008 ATNSALAKIQSVVNANAQALNSLLQQLFNKFGAISSSLQEILSRLDNLEAQVQIDRLINGRLTALNAYVSQQLSDITLIK 1087
Cdd:cd22380    399 ATNSALAKIQSVVNANAEALNNLLQQLSNRFGAISASLQEILSRLDALEAQAQIDRLINGRLTALNAYVSQQLSDSTLVK 478
                          490       500       510       520       530       540       550       560
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797 1088 AGASRAIEKVNECVKSQSPRINFCGNGNHILSLVQNAPYGLLFIHFSYKPTSFKTVLVSPGLCLSGDRGIAPKQGYFIKQ 1167
Cdd:cd22380    479 FSAAQAIEKVNECVKSQSPRINFCGNGNHILSLVQNAPYGLYFIHFSYVPTSFVTAKVSPGLCIAGDRGIAPKSGYFVNV 558
                          570       580       590       600       610       620       630       640
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797 1168 NDSWMFTGSSYYYPEPISDKNVVFMNSCSVNFTKAPFIYLNNSIPNLSDFEAELSLWFKNHTSIAPNLTFNSHINATFLD 1247
Cdd:cd22380    559 NNEWMFTGSGYYYPEPITDKNVVVMSSCAVNYTKAPDVMLNTSIPNLPDFKEELDQWFKNQTSVAPDLSLDEYINVTFLD 638
                          650       660
                   ....*....|....*....|....*
gi 1002351797 1248 LYYEMNVIQESIKSLNGSGYIPEAP 1272
Cdd:cd22380    639 LQDEMNRIQEAIKVLNESYINLKEI 663
HKU1_N5-like_CoV_Spike_S1_RBD cd21482
receptor-binding domain of the S1 subunit of the Spike (S) protein from human coronavirus HKU1, ...
294-597 0e+00

receptor-binding domain of the S1 subunit of the Spike (S) protein from human coronavirus HKU1, isolate N5 and isolate N2; This group contains the receptor-binding domain (RBD) of the S1 subunit of the spike (S) protein from human coronavirus (CoV) HKU1, isolates N5 and N2. HKU1 is a human betacoronavirus that causes mild yet prevalent respiratory disease, and is related to the zoonotic SARS and MERS betacoronaviruses, which have high fatality rates and pandemic potential. The CoV S protein is an envelope glycoprotein that plays the most important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains a hydrophobic fusion peptide and two heptad repeat regions. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-terminal domain (C-domain). Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBD of mouse hepatitis virus (MHV) is located at the NTD, most CoVs use the C-domain to bind their receptors. Although a protein receptor has not yet been identified for HKU1, antibodies against the C-domain, but not those against the NTD, blocked HKU1 infection of cells, suggesting that the S1 C-domain is the primary HKU1 receptor-binding site. Due to the key role of the S protein RBD in viral attachment, it is the major target for antibody-mediated neutralization. This model corresponds to the S1 subunit C-domain that serves as the RBD for most CoVs, and most likely, for HKU1.


:

Pssm-ID: 394829  Cd Length: 304  Bit Score: 601.67  E-value: 0e+00
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  294 SGFTVKPVATVYRRIPNLPDCDIDNWLNNVSVPSPLNWERRIFSNCNFNLSTLLRLVHVDSFSCNNLDKSKIFGSCFNSI 373
Cdd:cd21482      1 SGFTVKPVATVYRRIPNLPDCDIDNWLNNVSVPSPLNWERRIFSNCNFNLSTLLRLVHVDSFSCNNLDKSKIFGSCFNSI 80
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  374 TVDKFAIPNRRRDDLQLGSSGFLQSSNYKIDISSSSCQLYYSLPLVNVTINNFNPSSWNRRYGFGSFNLSSYDVVYSDHC 453
Cdd:cd21482     81 TVDKFAIPNRRRDDLQLGSSGFLQSSNYKIDISSSSCQLYYSLPLLNVTINNFNPSSWNRRYGFGSFNVSSYDVVYSDHC 160
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  454 FSVNSDFCPCADPSVVNSCAKSKPPSAICPAGTKYRHCDLDTTLYVKNWCRCSCLPDPISTYSPNTCPQKKVVVGIGEHC 533
Cdd:cd21482    161 FSVNSDFCPCADPSVVNSCVKSKPLSAICPAGTKYRHCDLDTTLYVKNWCRCSCLPDPISTYSPNTCPQKKVVVGIGEHC 240
                          250       260       270       280       290       300
                   ....*....|....*....|....*....|....*....|....*....|....*....|....
gi 1002351797  534 PGLGINEEKCGTQLNHSSCFCSPDAFLGWSFDSCISNNRCNIFSNFIFNGINSGTTCSNDLLYS 597
Cdd:cd21482    241 PGLGINEEKCGTQLNHSSCSCSPDAFLGWSFDSCISNNRCNIFSNFIFNGINSGTTCSNDLLYS 304
MHV-like_Spike_S1_NTD cd21625
N-terminal domain of the S1 subunit of the Spike (S) protein from murine hepatitis virus and ...
2-281 5.12e-177

N-terminal domain of the S1 subunit of the Spike (S) protein from murine hepatitis virus and related betacoronaviruses in the A lineage; This subfamily contains the N-terminal domain (NTD) of the S1 subunit of the Spike (S) proteins from betacoronaviruses in the embecovirus subgenera (A lineage), including murine hepatitis virus (MHV), human coronavirus (HCoV) HKU1 and OC43, and bovine CoV (BCoV). MHV is the most common viral pathogen in contemporary laboratory mouse colonies manifesting as a primary infection in the upper respiratory tract, while HCoV-HKU1 causes mild yet prevalent respiratory disease in humans. The CoV S protein is an envelope glycoprotein that plays the most important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains a hydrophobic fusion peptide and two heptad repeat regions. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-terminal domain (C-domain). Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While most CoVs, including SARS-CoV and MERS-CoV use the C-domain to bind their receptors, several CoVs in the A lineage use the NTD to bind their receptors. MHV binds its protein receptor, mouse carcinoembryonic antigen related cell adhesion molecule 1a (mCEACAM1a), through its S1 NTD. BCoV and HCoV-OC43 recognize a sugar moiety, 5-N-acetyl-9-O-acetylneuraminic acid (Neu5,9Ac2), on cell-surface glycoproteins or glycolipids; this binding is also through the S1 NTD. In addition, the S1 NTD contributes to the Spike trimer interface.


:

Pssm-ID: 394951  Cd Length: 284  Bit Score: 524.26  E-value: 5.12e-177
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797    2 IGDFNCTNSFINDYNKTIPRISEDVVDVSLGLGTYYVLNRVYLNTTLLFTGYFPKSGANFRDLALKGSIYLSTLWYKPPF 81
Cdd:cd21625      1 IGDFKCTTVSINDVNTGAPSISTETVDVSNGLGTYYVLDRVYLNTTLLLNGYYPTSGSTYRNLALKGTLLLSTLWFKPPF 80
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797   82 LSDFNNGIFSKVKNTKLYVNNTLYSEFSTIVIGSVFVNTSYTIVVQPHN--------GILEITACQYTMCEYPHTVCKSK 153
Cdd:cd21625     81 LSEFNNGIFAKVKNTKVSKNGVMYSEFPTIVIGSTFVNTSYTVVVQPHTgnsdnklqGILEISVCQYTMCEYPNTICKPN 160
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  154 -GSIRNESWHIDSSEPLCLFKKNFTYNVSADWLYFHFYQERGVFYAYYADVGMPTTFLFSLYLGTILSHYYVMPLTCNAI 232
Cdd:cd21625    161 lGNQRIELWHTDTGVPSCLYKRNFTYDVNADWLYFHFYQEGGTFYAYYADTGSVTTFLFSVYLGTVLSHYYVMPLTCNST 240
                          250       260       270       280
                   ....*....|....*....|....*....|....*....|....*....
gi 1002351797  233 ssntdNETLEYWVTPLSRRQYLLNFDEHGVITNAVDCSSSFLSEIQCKT 281
Cdd:cd21625    241 -----ALTLEYWVTPLTKRQYLLAFNQDGVITNAVDCASDFMSEIKCKT 284
Fibritin_C super family cl44324
Fibritin C-terminal region; This family features sequences bearing similarity to the ...
1258-1291 3.40e-08

Fibritin C-terminal region; This family features sequences bearing similarity to the C-terminal portion of the bacteriophage T4 protein fibritin. This protein is responsible for attachment of long tail fibres to virus particle, and forms the 'whiskers' or fibres on the neck of the virion. The region seen in this family contains an N-terminal coiled-coil portion and the C-terminal globular foldon domain (residues 457-486), which is essential for fibritin trimerization and folding. This domain consists of a beta-hairpin; three such hairpins come together in a beta-propeller-like arrangement in the trimer, which is stabilized by hydrogen bonds, salt bridges and hydrophobic interactions.


The actual alignment was detected with superfamily member pfam07921:

Pssm-ID: 254516 [Multi-domain]  Cd Length: 93  Bit Score: 52.46  E-value: 3.40e-08
                           10        20        30
                   ....*....|....*....|....*....|....
gi 1002351797 1258 SIKSLNGSGYIPEAPRDGQAYVRKDGEWVLLSTF 1291
Cdd:pfam07921   60 GVQALQESGKIDDAPDDGRWYVRKDGAWVLLSSI 93
 
Name Accession Description Interval E-value
HKU1-CoV-like_Spike_SD1-2_S1-S2_S2 cd22380
SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) ...
611-1272 0e+00

SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from human HKU1 and OC43 coronaviruses and related betacoronaviruses in the A lineage; This group contains the SD-1 and SD-2 subdomains of the S1 subunit C-terminal domain (C-domain), the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from betacoronaviruses in the embecovirus subgenus (A lineage), including highly pathogenic human coronaviruses (CoVs), HKU1 and OC43 CoVs, as well as murine hepatitis virus (MHV). The CoV S protein is an envelope glycoprotein that plays a very important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains the coronavirus fusion machinery and is primarily alpha-helical. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-domain. The S1 C-domain also contains two subdomains (SD-1 and SD-2), which connect the S1 and S2 subunits. Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBD of MHV is located at the NTD, most CoVs, including SARS-CoV-2, SARS-CoV and MERS-CoV use the C-domain to bind their receptors. The S2 subunit comprises the fusion peptide (FP), a second proteolytic site (S2'), followed by an internal fusion peptide (IFP) and two heptad-repeat domains (HR1 and HR2) preceding the transmembrane domain (TM). After binding of the S1 subunit RBD on the virion to its receptor on the target cell, the HR1 and HR2 domains interact with each other to form a six-helix bundle (6-HB) fusion core, bringing viral and cellular membranes into close proximity for fusion and infection. In order to catalyze the membrane fusion reaction, CoV S needs to be primed through cleavage at the S1/S2 and S2' sites. In the case of human-infecting coronaviruses such as SARS-CoV-2, HCoV-OC43, MERS-CoV, and HCoV-KU1, the spike protein contains an insertion of (R/K)-(2X)n-(R/K) (furin cleavage motif) at the S1/S2 site, which is absent in SARS-CoV and other SARS-related coronaviruses, as well as Rousettus bat coronavirus HKU9. The region modeled in this cd (SD-1 and SD-2, the S1/S2 cleavage region, and the S2 fusion subunit) plays an essential role in viral entry by initiating fusion of the viral and cellular membranes.


Pssm-ID: 411967 [Multi-domain]  Cd Length: 663  Bit Score: 1231.18  E-value: 0e+00
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  611 LYGITGQGIFKEVSAAYYNNWQNLLYDSNGNIIGFKDFLTNKTYTILPCYSGRVSAAFYQNSSSPALLYRNLKCSYVLNN 690
Cdd:cd22380      1 LYGITGQGIFKEVNADYYNSWQNLLYDSNGNLYGFRDYLTNKTYMIRSCYSGRVSAAFHANASEPALLYRNLKCSYVFNN 80
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  691 ISF--ISQPFYFDSYLGCVLNAVNLTSYSVSSCDLRMGSGFCIDYalPSSGGSGSGISSPYRFVTFEPFNVSFVNDSVET 768
Cdd:cd22380     81 TISreEQPLNYFDSYLGCVVNADNSTSSAVQTCDLRMGSGYCVDY--STSRRSRRSISTGYRFTTFEPFTVNLVNDSVEP 158
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  769 VGGLFEIQIPTNFTIAGHEEFIQTSSPKVTIDCSAFVCSNYAACHDLLSEYGTFCDNINSILNEVNDLLDITQLQVANAL 848
Cdd:cd22380    159 VGGLYEIQIPTNFTIGNHEEFIQTSSPKVTIDCAAFVCGDYAACRQQLVEYGSFCDNINAILNEVNELLDTTQLQVANSL 238
                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  849 MQGVTLSSNLNTNLHSDVDNIDFKSLLGCLGSQCG-SSSRSLLEDLLFNKVKLSDVGFVEAYNNCTGGSEIRDLLCVQSF 927
Cdd:cd22380    239 MQGVTLSSRLKDGINFNVDDINFSPVLGCLGSDCNaASSRSAIEDLLFDKVKLSDVGFVEAYNNCTGGAEIRDLLCVQSF 318
                          330       340       350       360       370       380       390       400
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  928 NGIKVLPPILSETQISGYTTAATVAAMFPPWSAAAGVPFSLNVQYRINGLGVTMDVLNKNQKLIANAFNKALLSIQNGFT 1007
Cdd:cd22380    319 NGIKVLPPVLSENQISGYTTAATAASLFPPWSAAAGVPFSLNVQYRINGLGVTMDVLSQNQKLIANAFNNALGAIQEGFD 398
                          410       420       430       440       450       460       470       480
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797 1008 ATNSALAKIQSVVNANAQALNSLLQQLFNKFGAISSSLQEILSRLDNLEAQVQIDRLINGRLTALNAYVSQQLSDITLIK 1087
Cdd:cd22380    399 ATNSALAKIQSVVNANAEALNNLLQQLSNRFGAISASLQEILSRLDALEAQAQIDRLINGRLTALNAYVSQQLSDSTLVK 478
                          490       500       510       520       530       540       550       560
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797 1088 AGASRAIEKVNECVKSQSPRINFCGNGNHILSLVQNAPYGLLFIHFSYKPTSFKTVLVSPGLCLSGDRGIAPKQGYFIKQ 1167
Cdd:cd22380    479 FSAAQAIEKVNECVKSQSPRINFCGNGNHILSLVQNAPYGLYFIHFSYVPTSFVTAKVSPGLCIAGDRGIAPKSGYFVNV 558
                          570       580       590       600       610       620       630       640
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797 1168 NDSWMFTGSSYYYPEPISDKNVVFMNSCSVNFTKAPFIYLNNSIPNLSDFEAELSLWFKNHTSIAPNLTFNSHINATFLD 1247
Cdd:cd22380    559 NNEWMFTGSGYYYPEPITDKNVVVMSSCAVNYTKAPDVMLNTSIPNLPDFKEELDQWFKNQTSVAPDLSLDEYINVTFLD 638
                          650       660
                   ....*....|....*....|....*
gi 1002351797 1248 LYYEMNVIQESIKSLNGSGYIPEAP 1272
Cdd:cd22380    639 LQDEMNRIQEAIKVLNESYINLKEI 663
CoV_S2 pfam01601
Coronavirus spike glycoprotein S2; The coronavirus spike glycoprotein forms the characteriztic ...
773-1265 0e+00

Coronavirus spike glycoprotein S2; The coronavirus spike glycoprotein forms the characteriztic 'corona' after which the group is named. The Spike glycoprotein is translated as a large polypeptide that is subsequently cleaved to S1 pfam01600 and S2,. The S2 subunit normally contains multiple key components, including one or more fusion peptides (FP), a second proteolytic site (S2') and two conserved heptad repeats (HRs), driving membrane penetration and virus-cell fusion. The HRs can trimerize into a coiled-coil structure built of three HR1-HR2 helical hairpins presenting as a canonical six-helix bundle and drag the virus envelope and the host cell bilayer into close proximity, preparing for fusion to occur.


Pssm-ID: 460263  Cd Length: 502  Bit Score: 633.15  E-value: 0e+00
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  773 FEIQIPTNFTIAGHEEFIQTSSPKVTIDCSAFVCSNYAACHDLLSEYGTFCDNINSILNEVNDLLDITQLQVANALMQGV 852
Cdd:pfam01601    1 GNISIPTNFTISVQTEYIQTTSPKVSVDCAQYVCNGNERCLQLLVQYGSFCSTIEQALQGSARLEDVEVLSMLSISNRAL 80
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  853 TLSSNLNTNlhsdvDNIDFKSLLGCLGSqcgssSRSLLEDLLFNKVKLSDVGFVEAYNNCTGGSEIRDLLCVQSFNGIKV 932
Cdd:pfam01601   81 TLATISNFG-----SDFNFSSFLPCLNS-----GRSAIEDLLFDKVVTSGLGTVDAYKKCTKGTSIADLVCAQYYNGIMV 150
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  933 LPPILSETQISGYTTAATVAAMFPPWS-AAAGVPFSLNVQYRINGLGVTMDVLNKNQKLIANAFNKALLSIQNGFTATNS 1011
Cdd:pfam01601  151 LPGVVDAEKMAMYTASLTGGMAFGGLTgAAAAIPFALAVQARLNYLGLQTDVLQENQKILANAFNNAVGNITDGFTTTAS 230
                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797 1012 ALAKIQSVVNANAQALNSLLQQLFNKFGAISSSLQEILSRLDNLEAQVQIDRLINGRLTALNAYVSQQLSDITLIKAGAS 1091
Cdd:pfam01601  231 ALSKIQDVVNANAQALNQLTQQLSNNFGAISSSIQDIYSRLDQLEADAQVDRLINGRLAALNAFVTQQLTKASEVKASRQ 310
                          330       340       350       360       370       380       390       400
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797 1092 RAIEKVNECVKSQSPRINFCGNGNHILSLVQNAPYGLLFIHFSYKPTSFKTVLVSPGLCLSGDRGIAPKQGYFIKQNDS- 1170
Cdd:pfam01601  311 LAQQKVNECVKSQSSRYGFCGNGTHLFSLPQAAPNGIMFLHTVLVPTEYITVKATPGLCVNGTTGYAPRDGQFVLNNTSn 390
                          410       420       430       440       450       460       470       480
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797 1171 WMFTGSSYYYPEPISDKNVVFMNSCSVNFTKAPFIYLNNSIPNLSDFEAELSLWFKNHTSIAPNLTFnSHINATFLDLYY 1250
Cdd:pfam01601  391 WYITPRNMYQPRPITGSDFVQISSCDVNFVNITNTKLPPLIPDYVDFNKELEDIYKNLNSTLPDLDL-DIFNATILNLTD 469
                          490
                   ....*....|....*...
gi 1002351797 1251 EMNVI---QESIKSLNGS 1265
Cdd:pfam01601  470 EIKDLerlQELIDNLNQT 487
HKU1_N5-like_CoV_Spike_S1_RBD cd21482
receptor-binding domain of the S1 subunit of the Spike (S) protein from human coronavirus HKU1, ...
294-597 0e+00

receptor-binding domain of the S1 subunit of the Spike (S) protein from human coronavirus HKU1, isolate N5 and isolate N2; This group contains the receptor-binding domain (RBD) of the S1 subunit of the spike (S) protein from human coronavirus (CoV) HKU1, isolates N5 and N2. HKU1 is a human betacoronavirus that causes mild yet prevalent respiratory disease, and is related to the zoonotic SARS and MERS betacoronaviruses, which have high fatality rates and pandemic potential. The CoV S protein is an envelope glycoprotein that plays the most important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains a hydrophobic fusion peptide and two heptad repeat regions. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-terminal domain (C-domain). Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBD of mouse hepatitis virus (MHV) is located at the NTD, most CoVs use the C-domain to bind their receptors. Although a protein receptor has not yet been identified for HKU1, antibodies against the C-domain, but not those against the NTD, blocked HKU1 infection of cells, suggesting that the S1 C-domain is the primary HKU1 receptor-binding site. Due to the key role of the S protein RBD in viral attachment, it is the major target for antibody-mediated neutralization. This model corresponds to the S1 subunit C-domain that serves as the RBD for most CoVs, and most likely, for HKU1.


Pssm-ID: 394829  Cd Length: 304  Bit Score: 601.67  E-value: 0e+00
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  294 SGFTVKPVATVYRRIPNLPDCDIDNWLNNVSVPSPLNWERRIFSNCNFNLSTLLRLVHVDSFSCNNLDKSKIFGSCFNSI 373
Cdd:cd21482      1 SGFTVKPVATVYRRIPNLPDCDIDNWLNNVSVPSPLNWERRIFSNCNFNLSTLLRLVHVDSFSCNNLDKSKIFGSCFNSI 80
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  374 TVDKFAIPNRRRDDLQLGSSGFLQSSNYKIDISSSSCQLYYSLPLVNVTINNFNPSSWNRRYGFGSFNLSSYDVVYSDHC 453
Cdd:cd21482     81 TVDKFAIPNRRRDDLQLGSSGFLQSSNYKIDISSSSCQLYYSLPLLNVTINNFNPSSWNRRYGFGSFNVSSYDVVYSDHC 160
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  454 FSVNSDFCPCADPSVVNSCAKSKPPSAICPAGTKYRHCDLDTTLYVKNWCRCSCLPDPISTYSPNTCPQKKVVVGIGEHC 533
Cdd:cd21482    161 FSVNSDFCPCADPSVVNSCVKSKPLSAICPAGTKYRHCDLDTTLYVKNWCRCSCLPDPISTYSPNTCPQKKVVVGIGEHC 240
                          250       260       270       280       290       300
                   ....*....|....*....|....*....|....*....|....*....|....*....|....
gi 1002351797  534 PGLGINEEKCGTQLNHSSCFCSPDAFLGWSFDSCISNNRCNIFSNFIFNGINSGTTCSNDLLYS 597
Cdd:cd21482    241 PGLGINEEKCGTQLNHSSCSCSPDAFLGWSFDSCISNNRCNIFSNFIFNGINSGTTCSNDLLYS 304
MHV-like_Spike_S1_NTD cd21625
N-terminal domain of the S1 subunit of the Spike (S) protein from murine hepatitis virus and ...
2-281 5.12e-177

N-terminal domain of the S1 subunit of the Spike (S) protein from murine hepatitis virus and related betacoronaviruses in the A lineage; This subfamily contains the N-terminal domain (NTD) of the S1 subunit of the Spike (S) proteins from betacoronaviruses in the embecovirus subgenera (A lineage), including murine hepatitis virus (MHV), human coronavirus (HCoV) HKU1 and OC43, and bovine CoV (BCoV). MHV is the most common viral pathogen in contemporary laboratory mouse colonies manifesting as a primary infection in the upper respiratory tract, while HCoV-HKU1 causes mild yet prevalent respiratory disease in humans. The CoV S protein is an envelope glycoprotein that plays the most important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains a hydrophobic fusion peptide and two heptad repeat regions. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-terminal domain (C-domain). Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While most CoVs, including SARS-CoV and MERS-CoV use the C-domain to bind their receptors, several CoVs in the A lineage use the NTD to bind their receptors. MHV binds its protein receptor, mouse carcinoembryonic antigen related cell adhesion molecule 1a (mCEACAM1a), through its S1 NTD. BCoV and HCoV-OC43 recognize a sugar moiety, 5-N-acetyl-9-O-acetylneuraminic acid (Neu5,9Ac2), on cell-surface glycoproteins or glycolipids; this binding is also through the S1 NTD. In addition, the S1 NTD contributes to the Spike trimer interface.


Pssm-ID: 394951  Cd Length: 284  Bit Score: 524.26  E-value: 5.12e-177
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797    2 IGDFNCTNSFINDYNKTIPRISEDVVDVSLGLGTYYVLNRVYLNTTLLFTGYFPKSGANFRDLALKGSIYLSTLWYKPPF 81
Cdd:cd21625      1 IGDFKCTTVSINDVNTGAPSISTETVDVSNGLGTYYVLDRVYLNTTLLLNGYYPTSGSTYRNLALKGTLLLSTLWFKPPF 80
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797   82 LSDFNNGIFSKVKNTKLYVNNTLYSEFSTIVIGSVFVNTSYTIVVQPHN--------GILEITACQYTMCEYPHTVCKSK 153
Cdd:cd21625     81 LSEFNNGIFAKVKNTKVSKNGVMYSEFPTIVIGSTFVNTSYTVVVQPHTgnsdnklqGILEISVCQYTMCEYPNTICKPN 160
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  154 -GSIRNESWHIDSSEPLCLFKKNFTYNVSADWLYFHFYQERGVFYAYYADVGMPTTFLFSLYLGTILSHYYVMPLTCNAI 232
Cdd:cd21625    161 lGNQRIELWHTDTGVPSCLYKRNFTYDVNADWLYFHFYQEGGTFYAYYADTGSVTTFLFSVYLGTVLSHYYVMPLTCNST 240
                          250       260       270       280
                   ....*....|....*....|....*....|....*....|....*....
gi 1002351797  233 ssntdNETLEYWVTPLSRRQYLLNFDEHGVITNAVDCSSSFLSEIQCKT 281
Cdd:cd21625    241 -----ALTLEYWVTPLTKRQYLLAFNQDGVITNAVDCASDFMSEIKCKT 284
bCoV_S1_N pfam16451
Betacoronavirus-like spike glycoprotein S1, N-terminal; This entry represents the N-terminal ...
28-312 2.68e-75

Betacoronavirus-like spike glycoprotein S1, N-terminal; This entry represents the N-terminal domain of the betacoronavirus-like trimeric spike glycoprotein. The distal S1 subunit of the coronavirus spike protein is responsible for receptor binding. S1 contains two domains; an N-terminal galectin-like domain (NTD) and a receptor-binding domain (S1 RBD) also referred to as the S1 CTD or domain B. Either the S1 NTD or S1 RBD, or occasionally both, are involved in binding to host receptors. S1 NTD is located on the side of the spike trimer and mainly recognizes sugar receptors. For many betacoronaviruses (b-CoVs), for example mouse hepatitis virus (MHV), the RBD is located in the NTD. The structure of the MHV S1 NTD showed the same fold as human galectins (galactose-binding lectin), however it does not bind any sugar; instead, it binds to the carcinoembryonic antigen cell-adhesion molecule CEACAM1) through protein-protein interactions. All three CEACAM21a-binding sites in MHV spikes can be fully occupied by CEACAM1a. It has been shown that CEACAM1a binding to the MHV spike weakens the interactions between S1 and S2 and facilitates the proteolysis of the spike protein and dissociation of S1. The homologous bovine CoV (BCov) S1 NTD also possesses a galectin fold but binds to sialic acid-containing moieties on host cell membranes, as does the NTD of three other group A b-Covs, namely human CoV (HCoV) OC43, avian b-CoV, and infectious bronchitis virus (IBV). Despite the S1 NTD of human respiratory b-CoV HKU1 being highly homologous to the NTDs of MHV and bovine CoV, it does not bind to either sugar or human carcinoembryonic antigen-related cell adhesion molecules (CEACAMs) and the RBD is found instead in the S1 RBD domain.


Pssm-ID: 465119  Cd Length: 296  Bit Score: 251.95  E-value: 2.68e-75
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797   28 DVSLGLGTYYVLNRVYLNTTLLFTGYFPKSGANFRDLALKGSIYLSTLWYKPPFLSdFNNGIFSKVKNTKLYVNNTLYSE 107
Cdd:pfam16451    1 DVSKADGTYYLPDRVYSNTTTLRQGLFPKQGDNVTNYVYSPAHHCGKRNFSTPFLP-FGDGIFVHIGNASNATGGRIISE 79
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  108 FSTIVIGSVFVNTSYTIVVQPHN--GILEITACQYTMCEYPHTVCKSKGS--IRNESWHIDSSEPLCLFKKNFTYNVSAD 183
Cdd:pfam16451   80 PPAFVFGSTFGNTSHTLIIAPDScqTNLTILVCNFTLCANPVTACRWGAGnyNANNSLVYFKNAINCTFNRTYNITFDTS 159
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  184 WLYFHFYQERGVFYAYYA------DVGMPTTFLF-SLYLGTILSHYYVMPLTCNAISSNTdNETLEYWVTPLSRRQYLLN 256
Cdd:pfam16451  160 LIYFGFKQQDGGFHIYYSywlpdlDSGPPTLFPFaTLPLGINITYFQVIPSSIRSTQNCR-RANAAYYVAPLKPSTFLLD 238
                          250       260       270       280       290
                   ....*....|....*....|....*....|....*....|....*....|....*.
gi 1002351797  257 FDEHGVITNAVDCSSSFLSEIQCKTQSFAPNTGVYDLSGFTVKPVATVYRRIPNLP 312
Cdd:pfam16451  239 FDVNGYITNAVDCSFDPLSELKCSTGSFEPDTGVYSTSSYRAQPVGSVYVRQPNVT 294
bCoV_S1_RBD pfam09408
Betacoronavirus spike glycoprotein S1, receptor binding; This entry represents the receptor ...
326-483 1.22e-30

Betacoronavirus spike glycoprotein S1, receptor binding; This entry represents the receptor binding domain (S1 RBD) of the betacoronavirus spike glycoprotein. The spike glycoprotein is arranged in trimers on the surface of the viral membrane and is essential for viral entry. The spike protein is translated as a large polypeptide that is subsequently cleaved to the distal S1, responsible for receptor binding, and the membrane-anchored S2 responsible for membrane fusion. The coronavirus (SARS-CoV) S1 subunit is composed of two distinct domains: an N-terminal domain (S1 NTD) and a receptor-binding domain (S1 RBD) also referred to as the S1 CTD or domain B. Each of these domains have been implicated in binding to host receptors. However, most coronaviruses are not known to utilize both the S1 NTD and S1 RBD for viral entry. SARS-CoV makes use of its S1 RBD to bind to the human angiotensin-converting enzyme 2 (ACE2) as its host receptor.


Pssm-ID: 462789  Cd Length: 156  Bit Score: 118.76  E-value: 1.22e-30
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  326 PSPLNWERRIFSNCNFNLSTLLRLVHVDSFSCNNLDKSKIFGSCFNSITVDKFAIPNRRRDDLQLGSSGFLQSSNYKIDI 405
Cdd:pfam09408    1 PSPANWERKTFSNCNFDFSVLLSLLQVSSFKCYGVSPSKLADMCYGSVTIDYFAIPETHKSNLQPGSPGAISKYNYKLPD 80
                           90       100       110       120       130       140       150
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 1002351797  406 SSSSCQLYYSLP-LVNVTINNFNPSSWNRRYGFGSFNLSSYDVVYSDHCFSVNSDFCPCAdpsVVNSCAKSKPPSAICP 483
Cdd:pfam09408   81 DFYGCVLAFNVNaNTNYAFADNYPYRYIKPGQYQPCNSFVSTVPNSPDGHYCTPSSFNGV---VVITLKPATGSNLVCP 156
Fibritin_C pfam07921
Fibritin C-terminal region; This family features sequences bearing similarity to the ...
1258-1291 3.40e-08

Fibritin C-terminal region; This family features sequences bearing similarity to the C-terminal portion of the bacteriophage T4 protein fibritin. This protein is responsible for attachment of long tail fibres to virus particle, and forms the 'whiskers' or fibres on the neck of the virion. The region seen in this family contains an N-terminal coiled-coil portion and the C-terminal globular foldon domain (residues 457-486), which is essential for fibritin trimerization and folding. This domain consists of a beta-hairpin; three such hairpins come together in a beta-propeller-like arrangement in the trimer, which is stabilized by hydrogen bonds, salt bridges and hydrophobic interactions.


Pssm-ID: 254516 [Multi-domain]  Cd Length: 93  Bit Score: 52.46  E-value: 3.40e-08
                           10        20        30
                   ....*....|....*....|....*....|....
gi 1002351797 1258 SIKSLNGSGYIPEAPRDGQAYVRKDGEWVLLSTF 1291
Cdd:pfam07921   60 GVQALQESGKIDDAPDDGRWYVRKDGAWVLLSSI 93
wac PHA02607
fibritin; Provisional
1255-1292 1.72e-06

fibritin; Provisional


Pssm-ID: 177432 [Multi-domain]  Cd Length: 454  Bit Score: 51.95  E-value: 1.72e-06
                           10        20        30        40
                   ....*....|....*....|....*....|....*....|
gi 1002351797 1255 IQESIKSL--NGSGYIPEAPRDGQAYVRKDGEWVLLSTFL 1292
Cdd:PHA02607   412 LKKTVKDLetQIAGKLDDAPSDGSWYVRKNGAWVEVSTGL 451
 
Name Accession Description Interval E-value
HKU1-CoV-like_Spike_SD1-2_S1-S2_S2 cd22380
SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) ...
611-1272 0e+00

SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from human HKU1 and OC43 coronaviruses and related betacoronaviruses in the A lineage; This group contains the SD-1 and SD-2 subdomains of the S1 subunit C-terminal domain (C-domain), the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from betacoronaviruses in the embecovirus subgenus (A lineage), including highly pathogenic human coronaviruses (CoVs), HKU1 and OC43 CoVs, as well as murine hepatitis virus (MHV). The CoV S protein is an envelope glycoprotein that plays a very important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains the coronavirus fusion machinery and is primarily alpha-helical. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-domain. The S1 C-domain also contains two subdomains (SD-1 and SD-2), which connect the S1 and S2 subunits. Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBD of MHV is located at the NTD, most CoVs, including SARS-CoV-2, SARS-CoV and MERS-CoV use the C-domain to bind their receptors. The S2 subunit comprises the fusion peptide (FP), a second proteolytic site (S2'), followed by an internal fusion peptide (IFP) and two heptad-repeat domains (HR1 and HR2) preceding the transmembrane domain (TM). After binding of the S1 subunit RBD on the virion to its receptor on the target cell, the HR1 and HR2 domains interact with each other to form a six-helix bundle (6-HB) fusion core, bringing viral and cellular membranes into close proximity for fusion and infection. In order to catalyze the membrane fusion reaction, CoV S needs to be primed through cleavage at the S1/S2 and S2' sites. In the case of human-infecting coronaviruses such as SARS-CoV-2, HCoV-OC43, MERS-CoV, and HCoV-KU1, the spike protein contains an insertion of (R/K)-(2X)n-(R/K) (furin cleavage motif) at the S1/S2 site, which is absent in SARS-CoV and other SARS-related coronaviruses, as well as Rousettus bat coronavirus HKU9. The region modeled in this cd (SD-1 and SD-2, the S1/S2 cleavage region, and the S2 fusion subunit) plays an essential role in viral entry by initiating fusion of the viral and cellular membranes.


Pssm-ID: 411967 [Multi-domain]  Cd Length: 663  Bit Score: 1231.18  E-value: 0e+00
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  611 LYGITGQGIFKEVSAAYYNNWQNLLYDSNGNIIGFKDFLTNKTYTILPCYSGRVSAAFYQNSSSPALLYRNLKCSYVLNN 690
Cdd:cd22380      1 LYGITGQGIFKEVNADYYNSWQNLLYDSNGNLYGFRDYLTNKTYMIRSCYSGRVSAAFHANASEPALLYRNLKCSYVFNN 80
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  691 ISF--ISQPFYFDSYLGCVLNAVNLTSYSVSSCDLRMGSGFCIDYalPSSGGSGSGISSPYRFVTFEPFNVSFVNDSVET 768
Cdd:cd22380     81 TISreEQPLNYFDSYLGCVVNADNSTSSAVQTCDLRMGSGYCVDY--STSRRSRRSISTGYRFTTFEPFTVNLVNDSVEP 158
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  769 VGGLFEIQIPTNFTIAGHEEFIQTSSPKVTIDCSAFVCSNYAACHDLLSEYGTFCDNINSILNEVNDLLDITQLQVANAL 848
Cdd:cd22380    159 VGGLYEIQIPTNFTIGNHEEFIQTSSPKVTIDCAAFVCGDYAACRQQLVEYGSFCDNINAILNEVNELLDTTQLQVANSL 238
                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  849 MQGVTLSSNLNTNLHSDVDNIDFKSLLGCLGSQCG-SSSRSLLEDLLFNKVKLSDVGFVEAYNNCTGGSEIRDLLCVQSF 927
Cdd:cd22380    239 MQGVTLSSRLKDGINFNVDDINFSPVLGCLGSDCNaASSRSAIEDLLFDKVKLSDVGFVEAYNNCTGGAEIRDLLCVQSF 318
                          330       340       350       360       370       380       390       400
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  928 NGIKVLPPILSETQISGYTTAATVAAMFPPWSAAAGVPFSLNVQYRINGLGVTMDVLNKNQKLIANAFNKALLSIQNGFT 1007
Cdd:cd22380    319 NGIKVLPPVLSENQISGYTTAATAASLFPPWSAAAGVPFSLNVQYRINGLGVTMDVLSQNQKLIANAFNNALGAIQEGFD 398
                          410       420       430       440       450       460       470       480
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797 1008 ATNSALAKIQSVVNANAQALNSLLQQLFNKFGAISSSLQEILSRLDNLEAQVQIDRLINGRLTALNAYVSQQLSDITLIK 1087
Cdd:cd22380    399 ATNSALAKIQSVVNANAEALNNLLQQLSNRFGAISASLQEILSRLDALEAQAQIDRLINGRLTALNAYVSQQLSDSTLVK 478
                          490       500       510       520       530       540       550       560
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797 1088 AGASRAIEKVNECVKSQSPRINFCGNGNHILSLVQNAPYGLLFIHFSYKPTSFKTVLVSPGLCLSGDRGIAPKQGYFIKQ 1167
Cdd:cd22380    479 FSAAQAIEKVNECVKSQSPRINFCGNGNHILSLVQNAPYGLYFIHFSYVPTSFVTAKVSPGLCIAGDRGIAPKSGYFVNV 558
                          570       580       590       600       610       620       630       640
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797 1168 NDSWMFTGSSYYYPEPISDKNVVFMNSCSVNFTKAPFIYLNNSIPNLSDFEAELSLWFKNHTSIAPNLTFNSHINATFLD 1247
Cdd:cd22380    559 NNEWMFTGSGYYYPEPITDKNVVVMSSCAVNYTKAPDVMLNTSIPNLPDFKEELDQWFKNQTSVAPDLSLDEYINVTFLD 638
                          650       660
                   ....*....|....*....|....*
gi 1002351797 1248 LYYEMNVIQESIKSLNGSGYIPEAP 1272
Cdd:cd22380    639 LQDEMNRIQEAIKVLNESYINLKEI 663
betaCoV_Spike_SD1-2_S1-S2_S2 cd22370
SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) ...
611-1272 0e+00

SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from betacoronaviruses; This family contains the SD-1 and SD-2 subdomains of the S1 subunit C-terminal domain (C-domain), the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from betacoronaviruses, including three highly pathogenic human coronaviruses (CoVs), Middle East respiratory syndrome coronavirus (MERS-CoV), Severe acute respiratory syndrome (SARS) coronavirus (SARS-CoV), and SARS coronavirus 2 (SARS-CoV-2), also known as a 2019 novel coronavirus (2019-nCoV). The CoV S protein is an envelope glycoprotein that plays a very important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains the coronavirus fusion machinery and is primarily alpha-helical. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-domain. The S1 C-domain also contains two subdomains (SD-1 and SD-2), which connect the S1 and S2 subunits. Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBD of mouse hepatitis virus (MHV) is located at the NTD, most CoVs, including SARS-CoV-2, SARS-CoV and MERS-CoV use the C-domain to bind their receptors. The S2 subunit comprises the fusion peptide (FP), a second proteolytic site (S2'), followed by an internal fusion peptide (IFP) and two heptad-repeat domains (HR1 and HR2) preceding the transmembrane domain (TM). After binding of the S1 subunit RBD on the virion to its receptor on the target cell, the HR1 and HR2 domains interact with each other to form a six-helix bundle (6-HB) fusion core, bringing viral and cellular membranes into close proximity for fusion and infection. In order to catalyze the membrane fusion reaction, CoV S needs to be primed through cleavage at the S1/S2 and S2' sites. In the case of human-infecting coronaviruses such as SARS-CoV-2, HCoV-OC43, MERS-CoV, and HKU1, the spike protein contains an insertion of (R/K)-(2X)n-(R/K) (furin cleavage motif) at the S1/S2 site, which is absent in SARS-CoV and other SARS-related coronaviruses, as well as Rousettus bat coronavirus HKU9. The region modeled in this cd (SD-1 and SD-2, the S1/S2 cleavage region, and the S2 fusion subunit) plays an essential role in viral entry by initiating fusion of the viral and cellular membranes.


Pssm-ID: 411957 [Multi-domain]  Cd Length: 667  Bit Score: 1035.51  E-value: 0e+00
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  611 LYGITGQGIFKEVSAAYYNnWQNLLYDSNGNIIGFKDFLTNKTYTILPCYSGRVSAAFYQNSS-SPALLYRNLKCSYVLN 689
Cdd:cd22370      1 LYGYTGTGVLTETNATFLP-FQNFGYDSNGNLIAFKDPQTNTIYTILPCVSGPVSVITPGNNTnEVAVLYNGLNCSEVPS 79
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  690 NISFIS----------QPFYFDSYLGCVLNAVNlTSYSVSSCDLRMGSGFCIDYALPSSGGSGSGISSPYRFVTFEPFNV 759
Cdd:cd22370     80 AISAVSltpwwrvyssTSNYFDTPVGCLLGAVN-SSNNSYECDLPLGAGLCASYTTQSVLRSRSVASRSIRLTTMSFFAE 158
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  760 SFVNdsVETVGGLFEIQIPTNFTIAGHEEFIQTSSPKVTIDCSAFVCSNYAACHDLLSEYGTFCDNINSILNEVNDLLDI 839
Cdd:cd22370    159 NSVD--VEVAYSNFSIQIPTNFTIAVTEEFIPTTMPKVTVDCAQYVCGDSSECSNLLLQYGTFCDNINRALTGVALLQDK 236
                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  840 TQLQVANALMQGVTLSsnlntNLHSDVDNIDFKSLLGCLGSQCGSSSRSLLEDLLFNKVKLSDVGFVEAYNNCTGGSEIR 919
Cdd:cd22370    237 NQLEVFASVKQIVKTP-----APLKDFGGFNFSSLLPCLGSNGGSSARSAIEDLLFNKVTLADVGFMKQYDDCTGGSAAR 311
                          330       340       350       360       370       380       390       400
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  920 DLLCVQSFNGIKVLPPILSETQISGYTTAATVAAMFP----PWSAAAGVPFSLNVQYRINGLGVTMDVLNKNQKLIANAF 995
Cdd:cd22370    312 DLICAQSFNGLKVLPPLLTDEMIAAYTSALLGGTATSgwtfGASSAAQIPFAMQMAYRFNGIGVTQQVLVENQKLIANKF 391
                          410       420       430       440       450       460       470       480
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  996 NKALLSIQNGFTATNSALAKIQSVVNANAQALNSLLQQLFNKFGAISSSLQEILSRLDNLEAQVQIDRLINGRLTALNAY 1075
Cdd:cd22370    392 NQALGSIQTGFTATNSALAKLQDVVNQNAQALNTLVKQLSNNFGAISSSLNDILSRLDKLEADVQIDRLINGRLQVLQTY 471
                          490       500       510       520       530       540       550       560
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797 1076 VSQQLSDITLIKAGASRAIEKVNECVKSQSPRINFCGNGNHILSLVQNAPYGLLFIHFSYKPTSFKTVLVSPGLCLSGDR 1155
Cdd:cd22370    472 VTQQLIRASEIRASAQLAAQKMSECVKGQSKRVDFCGNGTHLMSFPQSAPNGVVFLHVTYKPTSYKNVTTAPAICHNGKA 551
                          570       580       590       600       610       620       630       640
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797 1156 GIaPKQGYFIKQNDSWMFTGSSYYYPEPISDKNVVFMNSCSVNFTKAPFIYLNNSIPNLSDFEAELSLWFKNHTSIAPNL 1235
Cdd:cd22370    552 YF-PKEGVFVKNNNSWMFTGRNFYEPEIITTDNTFYSGSCDVNFTYVNNTVYNPLQPELDDFKAELDKFFKNHTSPDPNL 630
                          650       660       670
                   ....*....|....*....|....*....|....*..
gi 1002351797 1236 TFNSHINATFLDLYYEMNVIQESIKSLNGSGYIPEAP 1272
Cdd:cd22370    631 GDLSGINASFVDLQKEMDTLQEVVKQLNESLIDLKEL 667
CoV_S2 pfam01601
Coronavirus spike glycoprotein S2; The coronavirus spike glycoprotein forms the characteriztic ...
773-1265 0e+00

Coronavirus spike glycoprotein S2; The coronavirus spike glycoprotein forms the characteriztic 'corona' after which the group is named. The Spike glycoprotein is translated as a large polypeptide that is subsequently cleaved to S1 pfam01600 and S2,. The S2 subunit normally contains multiple key components, including one or more fusion peptides (FP), a second proteolytic site (S2') and two conserved heptad repeats (HRs), driving membrane penetration and virus-cell fusion. The HRs can trimerize into a coiled-coil structure built of three HR1-HR2 helical hairpins presenting as a canonical six-helix bundle and drag the virus envelope and the host cell bilayer into close proximity, preparing for fusion to occur.


Pssm-ID: 460263  Cd Length: 502  Bit Score: 633.15  E-value: 0e+00
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  773 FEIQIPTNFTIAGHEEFIQTSSPKVTIDCSAFVCSNYAACHDLLSEYGTFCDNINSILNEVNDLLDITQLQVANALMQGV 852
Cdd:pfam01601    1 GNISIPTNFTISVQTEYIQTTSPKVSVDCAQYVCNGNERCLQLLVQYGSFCSTIEQALQGSARLEDVEVLSMLSISNRAL 80
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  853 TLSSNLNTNlhsdvDNIDFKSLLGCLGSqcgssSRSLLEDLLFNKVKLSDVGFVEAYNNCTGGSEIRDLLCVQSFNGIKV 932
Cdd:pfam01601   81 TLATISNFG-----SDFNFSSFLPCLNS-----GRSAIEDLLFDKVVTSGLGTVDAYKKCTKGTSIADLVCAQYYNGIMV 150
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  933 LPPILSETQISGYTTAATVAAMFPPWS-AAAGVPFSLNVQYRINGLGVTMDVLNKNQKLIANAFNKALLSIQNGFTATNS 1011
Cdd:pfam01601  151 LPGVVDAEKMAMYTASLTGGMAFGGLTgAAAAIPFALAVQARLNYLGLQTDVLQENQKILANAFNNAVGNITDGFTTTAS 230
                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797 1012 ALAKIQSVVNANAQALNSLLQQLFNKFGAISSSLQEILSRLDNLEAQVQIDRLINGRLTALNAYVSQQLSDITLIKAGAS 1091
Cdd:pfam01601  231 ALSKIQDVVNANAQALNQLTQQLSNNFGAISSSIQDIYSRLDQLEADAQVDRLINGRLAALNAFVTQQLTKASEVKASRQ 310
                          330       340       350       360       370       380       390       400
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797 1092 RAIEKVNECVKSQSPRINFCGNGNHILSLVQNAPYGLLFIHFSYKPTSFKTVLVSPGLCLSGDRGIAPKQGYFIKQNDS- 1170
Cdd:pfam01601  311 LAQQKVNECVKSQSSRYGFCGNGTHLFSLPQAAPNGIMFLHTVLVPTEYITVKATPGLCVNGTTGYAPRDGQFVLNNTSn 390
                          410       420       430       440       450       460       470       480
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797 1171 WMFTGSSYYYPEPISDKNVVFMNSCSVNFTKAPFIYLNNSIPNLSDFEAELSLWFKNHTSIAPNLTFnSHINATFLDLYY 1250
Cdd:pfam01601  391 WYITPRNMYQPRPITGSDFVQISSCDVNFVNITNTKLPPLIPDYVDFNKELEDIYKNLNSTLPDLDL-DIFNATILNLTD 469
                          490
                   ....*....|....*...
gi 1002351797 1251 EMNVI---QESIKSLNGS 1265
Cdd:pfam01601  470 EIKDLerlQELIDNLNQT 487
HKU1_N5-like_CoV_Spike_S1_RBD cd21482
receptor-binding domain of the S1 subunit of the Spike (S) protein from human coronavirus HKU1, ...
294-597 0e+00

receptor-binding domain of the S1 subunit of the Spike (S) protein from human coronavirus HKU1, isolate N5 and isolate N2; This group contains the receptor-binding domain (RBD) of the S1 subunit of the spike (S) protein from human coronavirus (CoV) HKU1, isolates N5 and N2. HKU1 is a human betacoronavirus that causes mild yet prevalent respiratory disease, and is related to the zoonotic SARS and MERS betacoronaviruses, which have high fatality rates and pandemic potential. The CoV S protein is an envelope glycoprotein that plays the most important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains a hydrophobic fusion peptide and two heptad repeat regions. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-terminal domain (C-domain). Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBD of mouse hepatitis virus (MHV) is located at the NTD, most CoVs use the C-domain to bind their receptors. Although a protein receptor has not yet been identified for HKU1, antibodies against the C-domain, but not those against the NTD, blocked HKU1 infection of cells, suggesting that the S1 C-domain is the primary HKU1 receptor-binding site. Due to the key role of the S protein RBD in viral attachment, it is the major target for antibody-mediated neutralization. This model corresponds to the S1 subunit C-domain that serves as the RBD for most CoVs, and most likely, for HKU1.


Pssm-ID: 394829  Cd Length: 304  Bit Score: 601.67  E-value: 0e+00
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  294 SGFTVKPVATVYRRIPNLPDCDIDNWLNNVSVPSPLNWERRIFSNCNFNLSTLLRLVHVDSFSCNNLDKSKIFGSCFNSI 373
Cdd:cd21482      1 SGFTVKPVATVYRRIPNLPDCDIDNWLNNVSVPSPLNWERRIFSNCNFNLSTLLRLVHVDSFSCNNLDKSKIFGSCFNSI 80
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  374 TVDKFAIPNRRRDDLQLGSSGFLQSSNYKIDISSSSCQLYYSLPLVNVTINNFNPSSWNRRYGFGSFNLSSYDVVYSDHC 453
Cdd:cd21482     81 TVDKFAIPNRRRDDLQLGSSGFLQSSNYKIDISSSSCQLYYSLPLLNVTINNFNPSSWNRRYGFGSFNVSSYDVVYSDHC 160
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  454 FSVNSDFCPCADPSVVNSCAKSKPPSAICPAGTKYRHCDLDTTLYVKNWCRCSCLPDPISTYSPNTCPQKKVVVGIGEHC 533
Cdd:cd21482    161 FSVNSDFCPCADPSVVNSCVKSKPLSAICPAGTKYRHCDLDTTLYVKNWCRCSCLPDPISTYSPNTCPQKKVVVGIGEHC 240
                          250       260       270       280       290       300
                   ....*....|....*....|....*....|....*....|....*....|....*....|....
gi 1002351797  534 PGLGINEEKCGTQLNHSSCFCSPDAFLGWSFDSCISNNRCNIFSNFIFNGINSGTTCSNDLLYS 597
Cdd:cd21482    241 PGLGINEEKCGTQLNHSSCSCSPDAFLGWSFDSCISNNRCNIFSNFIFNGINSGTTCSNDLLYS 304
bat-HKU9-CoV-like_Spike_SD1-2_S1-S2_S2 cd22381
SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) ...
611-1265 1.17e-177

SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from Rousettus bat coronavirus HKU9 and related betacoronaviruses in the D lineage; This group contains the SD-1 and SD-2 subdomains of the S1 subunit C-terminal domain (C-domain), the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from betacoronaviruses in the nobecovirus subgenus (D lineage), including Rousettus bat coronavirus HKU9 (Ro-BatCoV HKU9). The CoV S protein is an envelope glycoprotein that plays a very important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains the coronavirus fusion machinery and is primarily alpha-helical. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-domain. The S1 C-domain also contains two subdomains (SD-1 and SD-2), which connect the S1 and S2 subunits. Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBD of mouse hepatitis virus (MHV) is located at the NTD, most CoVs, including SARS-CoV-2, SARS-CoV and MERS-CoV use the C-domain to bind their receptors. The S2 subunit comprises the fusion peptide (FP), a second proteolytic site (S2'), followed by an internal fusion peptide (IFP) and two heptad-repeat domains (HR1 and HR2) preceding the transmembrane domain (TM). After binding of the S1 subunit RBD on the virion to its receptor on the target cell, the HR1 and HR2 domains interact with each other to form a six-helix bundle (6-HB) fusion core, bringing viral and cellular membranes into close proximity for fusion and infection. In order to catalyze the membrane fusion reaction, CoV S needs to be primed through cleavage at the S1/S2 and S2' sites. In the case of human-infecting coronaviruses such as SARS-CoV-2, HCoV-OC43, MERS-CoV, and HCoV-KU1, the spike protein contains an insertion of (R/K)-(2X)n-(R/K) (furin cleavage motif) at the S1/S2 site, which is absent in SARS-CoV and other SARS-related coronaviruses, as well as Ro-BatCoV HKU9. The region modeled in this cd (SD-1 and SD-2, the S1/S2 cleavage region, and the S2 fusion subunit) plays an essential role in viral entry by initiating fusion of the viral and cellular membranes.


Pssm-ID: 411968 [Multi-domain]  Cd Length: 731  Bit Score: 543.58  E-value: 1.17e-177
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  611 LYGITGQGIFKEVSAAYYNNwQNLLYDSNGNIIGFKdfLTNKTYTILPCYSGRVSAAFYQNSSSpALLYRNLKCSYVLNN 690
Cdd:cd22381      1 LYGYTGTGVLSTSNLTIPDS-KVFSASSTGDIIAVS--VNGTVYSISPCVSVPISVGYDPGFER-ALLFNGLSCSERARA 76
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  691 ISFISQPF-----------YFDSYLGCVLNAVNLTSYSVSSCDLRMGSGFCIdyaLPSSGGSGSGISSPY-RFVTFEPFN 758
Cdd:cd22381     77 VSEPASDYwrasvsdgannTFDTPSGCVYNVINRTTITVNQCSMPLGNSLCL---VNNTTAVSARGSLSLlSLVTYDPLY 153
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  759 VSfvndSVETVGGLFEIQIPTNFTIAGHEEFIQTSSPKVTIDCSAFVCSNYAACHDLLSEYGTFCDNINSILNEVNDLLD 838
Cdd:cd22381    154 DS----SVTPLTPVYWVSIPTNFTLAATTEYIQTTAPKINIDCAKYLCGDSSRCLTVLLQYGTFCDDVNKALARVSTILD 229
                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  839 ITQLqvanALMQGVTLSSNLNTNLHSDVDnIDFKSLLGCLGSQCGSSS-RSLLEDLLFNKVKLSDVGFVEAYNNCTG--- 914
Cdd:cd22381    230 ASLV----SLVSELTSDVVRSENLAFDGD-YNFTGLMGCLGSNCNSKSyRSALSDLLYNKVKVADPGFMQSYQKCIDsqw 304
                          330       340       350       360       370       380       390       400
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  915 GSEIRDLLCVQSFNGIKVLPPILSETQISGYTTA---ATVAAMFPPWSAAAGV-PFSLNVQYRINGLGVTMDVLNKNQKL 990
Cdd:cd22381    305 GGNIRDLICTQTFNGISVLPPIVSPGMQALYTSLlvgAVASSGYTFGITSVGViPFATQLQFRLNGLGVTTQVLVENQKL 384
                          410       420       430       440       450       460       470       480
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  991 IANAFNKALLSIQNGFTATNSALAKIQSVVNANAQALNSLLQQLFNKFGAISSSLQEILSRLDNLEAQVQIDRLINGRLT 1070
Cdd:cd22381    385 IANSFNKALVSIQKGFDATNQALSKMQTVINQHAQQLQTLVQQLGNSFGAISSSINEIFSRLDGLEANAEVDRLINGRMV 464
                          490       500       510       520       530       540       550       560
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797 1071 ALNAYVSQQLSDITLIKAGASRAIEKVNECVKSQSPRINFCGNGNHILSLVQNAPYGLLFIHFSYKPTSFKTVLVSPGLC 1150
Cdd:cd22381    465 VLNTYVTQLLIQASEVRAQAALAKQKISECVKAQSLRNDFCGNGTHVLSIPQLAPNGVLFIHYSYQPTAYALVQTAAGLC 544
                          570       580       590       600       610       620       630       640
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797 1151 LSGDrGIAPKQGYFIKQNDS--WMFTGSSYYYPEPISDKNVVFMNSCSVNFTKAPFIYLNNSIPNLSDFEAELSLWFKNH 1228
Cdd:cd22381    545 FNGT-GYAPRGGLFVLPNNSnlWHFTKMNFYNPVNISYSNTQVLTSCSVNYTTVNYTVLNPSEPSDFNFQEEFDKWYKNQ 623
                          650       660       670
                   ....*....|....*....|....*....|....*...
gi 1002351797 1229 TSIApNLTFN-SHINATFLDLYYEMNVIQESIKSLNGS 1265
Cdd:cd22381    624 SSQF-NNTFNpSDFNFSTVDVNEQLATLTDVVKQLNES 660
MHV-like_Spike_S1_NTD cd21625
N-terminal domain of the S1 subunit of the Spike (S) protein from murine hepatitis virus and ...
2-281 5.12e-177

N-terminal domain of the S1 subunit of the Spike (S) protein from murine hepatitis virus and related betacoronaviruses in the A lineage; This subfamily contains the N-terminal domain (NTD) of the S1 subunit of the Spike (S) proteins from betacoronaviruses in the embecovirus subgenera (A lineage), including murine hepatitis virus (MHV), human coronavirus (HCoV) HKU1 and OC43, and bovine CoV (BCoV). MHV is the most common viral pathogen in contemporary laboratory mouse colonies manifesting as a primary infection in the upper respiratory tract, while HCoV-HKU1 causes mild yet prevalent respiratory disease in humans. The CoV S protein is an envelope glycoprotein that plays the most important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains a hydrophobic fusion peptide and two heptad repeat regions. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-terminal domain (C-domain). Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While most CoVs, including SARS-CoV and MERS-CoV use the C-domain to bind their receptors, several CoVs in the A lineage use the NTD to bind their receptors. MHV binds its protein receptor, mouse carcinoembryonic antigen related cell adhesion molecule 1a (mCEACAM1a), through its S1 NTD. BCoV and HCoV-OC43 recognize a sugar moiety, 5-N-acetyl-9-O-acetylneuraminic acid (Neu5,9Ac2), on cell-surface glycoproteins or glycolipids; this binding is also through the S1 NTD. In addition, the S1 NTD contributes to the Spike trimer interface.


Pssm-ID: 394951  Cd Length: 284  Bit Score: 524.26  E-value: 5.12e-177
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797    2 IGDFNCTNSFINDYNKTIPRISEDVVDVSLGLGTYYVLNRVYLNTTLLFTGYFPKSGANFRDLALKGSIYLSTLWYKPPF 81
Cdd:cd21625      1 IGDFKCTTVSINDVNTGAPSISTETVDVSNGLGTYYVLDRVYLNTTLLLNGYYPTSGSTYRNLALKGTLLLSTLWFKPPF 80
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797   82 LSDFNNGIFSKVKNTKLYVNNTLYSEFSTIVIGSVFVNTSYTIVVQPHN--------GILEITACQYTMCEYPHTVCKSK 153
Cdd:cd21625     81 LSEFNNGIFAKVKNTKVSKNGVMYSEFPTIVIGSTFVNTSYTVVVQPHTgnsdnklqGILEISVCQYTMCEYPNTICKPN 160
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  154 -GSIRNESWHIDSSEPLCLFKKNFTYNVSADWLYFHFYQERGVFYAYYADVGMPTTFLFSLYLGTILSHYYVMPLTCNAI 232
Cdd:cd21625    161 lGNQRIELWHTDTGVPSCLYKRNFTYDVNADWLYFHFYQEGGTFYAYYADTGSVTTFLFSVYLGTVLSHYYVMPLTCNST 240
                          250       260       270       280
                   ....*....|....*....|....*....|....*....|....*....
gi 1002351797  233 ssntdNETLEYWVTPLSRRQYLLNFDEHGVITNAVDCSSSFLSEIQCKT 281
Cdd:cd21625    241 -----ALTLEYWVTPLTKRQYLLAFNQDGVITNAVDCASDFMSEIKCKT 284
MERS-CoV-like_Spike_SD1-2_S1-S2_S2 cd22379
SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) ...
611-1268 1.51e-162

SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from Middle East respiratory syndrome coronavirus and related betacoronaviruses in the C lineage; This group contains the SD-1 and SD-2 subdomains of the S1 subunit C-terminal domain (C-domain), the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from betacoronaviruses in the merbecovirus subgenus (C lineage), including Middle East respiratory syndrome coronavirus (MERS-CoV). The CoV S protein is an envelope glycoprotein that plays a very important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains the coronavirus fusion machinery and is primarily alpha-helical. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-domain. The S1 C-domain also contains two subdomains (SD-1 and SD-2), which connect the S1 and S2 subunits. Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBD of mouse hepatitis virus (MHV) is located at the NTD, most CoVs, including SARS-CoV-2, SARS-CoV and MERS-CoV use the C-domain to bind their receptors. The S2 subunit comprises the fusion peptide (FP), a second proteolytic site (S2'), followed by an internal fusion peptide (IFP) and two heptad-repeat domains (HR1 and HR2) preceding the transmembrane domain (TM). After binding of the S1 subunit RBD on the virion to its receptor on the target cell, the HR1 and HR2 domains interact with each other to form a six-helix bundle (6-HB) fusion core, bringing viral and cellular membranes into close proximity for fusion and infection. In order to catalyze the membrane fusion reaction, CoV S needs to be primed through cleavage at the S1/S2 and S2' sites. In the case of human-infecting coronaviruses such as SARS-CoV-2, HCoV-OC43, MERS-CoV, and HCoV-KU1, the spike protein contains an insertion of (R/K)-(2X)n-(R/K) (furin cleavage motif) at the S1/S2 site, which is absent in SARS-CoV and other SARS-related coronaviruses, as well as Rousettus bat coronavirus HKU9. The region modeled in this cd (SD-1 and SD-2, the S1/S2 cleavage region, and the S2 fusion subunit) plays an essential role in viral entry by initiating fusion of the viral and cellular membranes.


Pssm-ID: 411966 [Multi-domain]  Cd Length: 682  Bit Score: 502.02  E-value: 1.51e-162
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  611 LYGITGQGIFKEVSAAYYNNwQNLLYDSNGNIIGFKDFLTNkTYTILPCYSGRVSAAFYQNSSSPALLYRNLKCSYVLNN 690
Cdd:cd22379      1 LYGVTGRGVFQNCTAVGIRQ-QRFVYDSFDNLVGYHSDDGN-YYCVRPCVSVPVSVIYDKSTNTHATLFGSVACEHISTM 78
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  691 ISFISQ-----------PFYFDSYLGCVLNAVNlTSYSVSSCDLRMGSGFCidyALPSSGGSGSGISSPYRFVTFEPFNV 759
Cdd:cd22379     79 MSQFSRstqsmlrrrstNGPLQTAVGCVIGLVN-TSLTVEDCKLPLGQSLC---AVPPTLTPRSVSSVPGEQLASINFNH 154
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  760 SFVNDSVETVGglFEIQIPTNFTIAGHEEFIQTSSPKVTIDCSAFVCSNYAACHDLLSEYGTFCDNINSILNEVNdlldI 839
Cdd:cd22379    155 PLQVDQLNSSG--FKVSIPTNFSFGVTQEYIQTTIQKVTVDCKQYVCNGFEKCEQLLREYGQFCSKINQALHGAN----L 228
                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  840 TQLQVANALMQGVTLSSN--LNTNLHSDVDnidfKSLLGCLGSQCGSSS-RSLLEDLLFNKVKLSDVGFVEAYNNCT--G 914
Cdd:cd22379    229 RQDDSVRNLFASIKTSQSqpLIAGLGGDFN----LTLLEPPSISTGSRSyRSAIEDLLFDKVTIADPGYMQGYDECMkqG 304
                          330       340       350       360       370       380       390       400
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  915 GSEIRDLLCVQSFNGIKVLPPILSETQISGYTTAATVAAMFPPW----SAAAGVPFSLNVQYRINGLGVTMDVLNKNQKL 990
Cdd:cd22379    305 PPSARDLICAQYVAGYKVLPPLYDVNMEAAYTSSLLGSIAGAGWtaglSSFAAIPFAQSIFYRLNGVGITQQVLSENQKL 384
                          410       420       430       440       450       460       470       480
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  991 IANAFNKALLSIQNGFTATNSALAKIQSVVNANAQALNSLLQQLFNKFGAISSSLQEILSRLDNLEAQVQIDRLINGRLT 1070
Cdd:cd22379    385 IANKFNQALGAMQTGFTTTNLAFQKVQDAVNANAQALSKLASELSNTFGAISSSIGDILKRLDVLEQEAQIDRLINGRLT 464
                          490       500       510       520       530       540       550       560
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797 1071 ALNAYVSQQLSDITLIKAGASRAIEKVNECVKSQSPRINFCGNGNHILSLVQNAPYGLLFIHFSYKPTSFKTVLVSPGLC 1150
Cdd:cd22379    465 SLNAFVAQQLVRSETAARSAQLAKDKVNECVKSQSKRNGFCGQGTHIVSFVINAPNGLYFFHVGYVPTNHVNVTAAYGLC 544
                          570       580       590       600       610       620       630       640
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797 1151 LSGD--RGIAPKQGYFIKQN-----DSWMFTGSSYYYPEPISDKNVVFMnSCSVNF----TKAPFIYLNNSIPnlSDFEA 1219
Cdd:cd22379    545 DSANptNCIAPVNGYFIKNNttrivDEWSYTGSSFYAPEPITSANTRYV-SPDVTFqnlsNNLPPPLLSNSTD--IDFKD 621
                          650       660       670       680
                   ....*....|....*....|....*....|....*....|....*....
gi 1002351797 1220 ELSLWFKNHTSIAPNLTFNSHINATFLDLYYEMNVIQESIKSLNGSgYI 1268
Cdd:cd22379    622 ELEEFFKNVSSQIPNFGSISQINTTLLDLSDEMLSLQQVVKALNES-YI 669
HKU1_N1_CoV_Spike_S1_RBD cd21483
receptor-binding domain of the S1 subunit of the Spike (S) protein from human coronavirus HKU1, ...
294-595 1.06e-159

receptor-binding domain of the S1 subunit of the Spike (S) protein from human coronavirus HKU1, isolate N1; This group contains the receptor-binding domain (RBD) of the S1 subunit of the spike (S) protein from human coronavirus (CoV) HKU1, isolate N1. HKU1 is a human betacoronavirus that causes mild yet prevalent respiratory disease, and is related to the zoonotic SARS and MERS betacoronaviruses, which have high fatality rates and pandemic potential. The CoV S protein is an envelope glycoprotein that plays the most important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains a hydrophobic fusion peptide and two heptad repeat regions. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-terminal domain (C-domain). Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBD of mouse hepatitis virus (MHV) is located at the NTD, most CoVs use the C-domain to bind their receptors. Although a protein receptor has not yet been identified for HKU1, antibodies against the C-domain, but not those against the NTD, blocked HKU1 infection of cells, suggesting that the S1 C-domain is the primary HKU1 receptor-binding site. Due to the key role of the S protein RBD in viral attachment, it is the major target for antibody-mediated neutralization. This model corresponds to the S1 subunit C-domain that serves as the RBD for most CoVs, and most likely, for HKU1.


Pssm-ID: 394830  Cd Length: 306  Bit Score: 479.99  E-value: 1.06e-159
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  294 SGFTVKPVATVYRRIPNLPDCDIDNWLNNVSVPSPLNWERRIFSNCNFNLSTLLRLVHVDSFSCNNLDKSKIFGSCFNSI 373
Cdd:cd21483      1 SGFTVKPVATVHRRIPDLPDCDIDKWLNNFNVPSPLNWERKIFSNCNFNLSTLLRLVHTDSFSCNNFDESKIYGSCFKSI 80
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  374 TVDKFAIPNRRRDDLQLGSSGFLQSSNYKIDISSSSCQLYYSLPLVNVTINNFNPSSWNRRYGFGSFNLSSYDVVYSDHC 453
Cdd:cd21483     81 VLDKFAIPNSRRSDLQLGSSGFLQSSNYKIDTTSSSCQLYYSLPAINVTINNYNPSSWNRRYGFNNFNLSSHSVVYSRYC 160
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  454 FSVNSDFCPCADPSVVNSCAKSKPPSAICPAGTKYRHCDLDTTLYVKNWCRCSCLPDPISTYSPNTCPQKKVVVGIGEHC 533
Cdd:cd21483    161 FSVNNTFCPCAKPSFASSCKSHKPPSASCPIGTNYRSCESTTVLDHTDWCRCSCLPDPITAYDPRSCSQKKSLVGVGEHC 240
                          250       260       270       280       290       300
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 1002351797  534 PGLGINEEKCGTqLNHS---SCFCSPDAFLGWSFDSCISNNRCNIFSNFIFNGINSGTTCSNDLL 595
Cdd:cd21483    241 AGFGVDEEKCGV-LDGSynvSCLCSTDAFLGWSYDTCVSNNRCNIFSNFILNGINSGTTCSNDLL 304
CoV_Spike_S1-S2_S2 cd21698
S1/S2 cleavage region and the S2 fusion subunit of coronavirus spike (S) proteins; This model ...
774-1265 3.12e-150

S1/S2 cleavage region and the S2 fusion subunit of coronavirus spike (S) proteins; This model represents the S1/S2 cleavage region and the S2 subunit of the spike (S) glycoprotein from coronavirus (CoVs), including three highly pathogenic human CoVs, Middle East respiratory syndrome coronavirus (MERS-CoV), Severe acute respiratory syndrome (SARS) coronavirus (SARS-CoV), and SARS coronavirus 2 (SARS-CoV-2), also known as a 2019 novel coronavirus (2019-nCoV). The CoV S protein is an envelope glycoprotein that plays a very important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains the coronavirus fusion machinery and is primarily alpha-helical. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-terminal domain (C-domain). S1 C-domain also contains two subdomains (SD-1 and SD-2), which connect S1 and S2. Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBD of mouse hepatitis virus (MHV) is located at the NTD, most CoVs, including SARS-CoV-2, SARS-CoV, and MERS-CoV use the C-domain to bind their receptors. The S2 subunit comprises the fusion peptide (FP), a second proteolytic site (S2'), followed by an internal fusion peptide (IFP), and two heptad-repeat domains (HR1 and HR2) preceding the transmembrane domain (TM). After binding of the S1 subunit RBD on the virion to its receptor on the target cell, the HR1 and HR2 domains interact with each other to form a six-helix bundle (6-HB) fusion core, bringing viral and cellular membranes into close proximity for fusion and infection. In order to catalyze the membrane fusion reaction, CoV S needs to be primed through cleavage at the S1/S2 and S2' sites. Notably, SARS-CoV-2 has a functional polybasic (furin) cleavage site through the insertion of PRRAR*SV (* indicates the cleavage site) at the S1/S2 interface, which is absent in SARS-CoV and other SARS-related CoVs. The S1/S2 cleavage region and the S2 fusion subunit play an essential role in viral entry by initiating fusion of the viral and cellular membranes.


Pssm-ID: 411955 [Multi-domain]  Cd Length: 523  Bit Score: 463.81  E-value: 3.12e-150
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  774 EIQIPTNFTIAGHEEFIQTSSPKVTIDCSAFVCSNYAACHDLLSEYGTFCDNINSILNEVNDLLDitqLQVANALMQGVT 853
Cdd:cd21698     32 NIAIPSNFTLSVTTEYLQVTMTKVSVDCTTYVCGGSPRCKNLLLQYGSACDTIEQALRGIAVLED---SEVSNMFSTSKQ 108
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  854 LSSNLNTnlhSDVDNIDFKSLLGclgSQCGSSSRSLLEDLLFNKVKLSDVGFVEAYNNCTGGSEIRDLLCVQSFNGIKVL 933
Cdd:cd21698    109 ALKLAII---KSFGGFNFSQILP---TPSRPSGRSAIEDLLFTKVVTAGLGTVDQYKNCTKGIAIADLACAQYYNGIMVL 182
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  934 PPILSETQISGYTTAATVAAMFPPWSAAAGVPFSLNVQYRINGLGVTMDVLNKNQKLIANAFNKALLSIQNGFTATNSAL 1013
Cdd:cd21698    183 PPVADAEKMAMYTGSLTAGMVFGGITAAAAIPFSLAMQARLNYVGLQQNVLLENQKLLANSFNKAIGNISDAFSSTSSAL 262
                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797 1014 AKIQSVVNANAQALNSLLQQLFNKFGAISSSLQEILSRLDNLEAQVQIDRLINGRLTALNAYVSQQLSDITLIKAGASRA 1093
Cdd:cd21698    263 QKIQDVVNQQAQALNTLTSQLSNNFGAISSSIQDIYQRLDKLEADVQVDRLITGRLAALNAFVTQQLIKAAEVRQSRRLA 342
                          330       340       350       360       370       380       390       400
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797 1094 IEKVNECVKSQSPRINFCGNGNHILSLVQNAPYGLLFIHFSYKPTSFKTVLVSPGLCLSGDRGIAPK-QGYFIKQNDSWM 1172
Cdd:cd21698    343 QQKINECVKSQSSRYGFCGNGTHLFSIPQSAPSGIVFLHTVLVPTSYKNVTAYPGICVDGKAGSPLEgPLVFIQNNNHWF 422
                          410       420       430       440       450       460       470       480
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797 1173 FTGSSYYYPEPISDKNVVFMNSCSVNFTkapfiYLNNS------IPNLSDFEAELSLWFKNHTS-IAPNLTFNShINATF 1245
Cdd:cd21698    423 VTPRNMYEPRIITTADFVQITSCDANVT-----IVNNTvnldpvIPDYVDVNEELDDYIQNLPNhTLPDLDLSG-YNATI 496
                          490       500
                   ....*....|....*....|
gi 1002351797 1246 LDLYYEMNVIQESIKSLNGS 1265
Cdd:cd21698    497 LNISSEIDRLNEVAKNLNQS 516
gammaCoV_Spike_SD1-2_S1-S2_S2 cd22372
SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) ...
601-1265 3.68e-139

SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from avian infectious bronchitis coronavirus (IBV) and related gammacoronaviruses; This group contains the SD-1 and SD-2 subdomains of the S1 subunit C-terminal domain (C-domain), the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from gammacoronaviruses, including avian infectious bronchitis virus, and Beluga whale coronavirus SW1 (whale-CoV SW1). The CoV S protein is an envelope glycoprotein that plays a very important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains the coronavirus fusion machinery and is primarily alpha-helical. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-domain. The S1 C-domain also contains two subdomains (SD-1 and SD-2), which connect the S1 and S2 subunits. Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBD of mouse hepatitis virus (MHV) is located at the NTD, most CoVs, including SARS-CoV-2, SARS-CoV and MERS-CoV use the C-domain to bind their receptors. The S2 subunit comprises the fusion peptide (FP), a second proteolytic site (S2'), followed by an internal fusion peptide (IFP) and two heptad-repeat domains (HR1 and HR2) preceding the transmembrane domain (TM). After binding of the S1 subunit RBD on the virion to its receptor on the target cell, the HR1 and HR2 domains interact with each other to form a six-helix bundle (6-HB) fusion core, bringing viral and cellular membranes into close proximity for fusion and infection. In order to catalyze the membrane fusion reaction, CoV S needs to be primed through cleavage at the S1/S2 and S2' sites. In the case of human-infecting coronaviruses such as SARS-CoV-2, HCoV-OC43, MERS-CoV, and HCoV-KU1, the spike protein contains an insertion of (R/K)-(2X)n-(R/K) (furin cleavage motif) at the S1/S2 site, which is absent in SARS-CoV and other SARS-related coronaviruses, as well as Ro-BatCoV HKU9. The region modeled in this cd (SD-1 and SD-2, the S1/S2 cleavage region, and the S2 fusion subunit) plays an essential role in viral entry by initiating fusion of the viral and cellular membranes.


Pssm-ID: 411959 [Multi-domain]  Cd Length: 661  Bit Score: 439.42  E-value: 3.68e-139
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  601 ISTGVCVNYDLYGITGQGIFKEVSAAYYNNwqNLLYDSNGNII---GFKDFLTNKT------YTILPCysGRVSAAFYQN 671
Cdd:cd22372      4 ITLNKCVDYNIYGRVGQGFITNVTDSAADY--NYLADGGLAILdtsGAIDIFVVQGeyglnyYKVNPC--EDVNQQFVVS 79
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  672 SSSPA--LLYRNLKCSYVLNNisfisqPFYFDSYLGcVLNAVNLTSYSVSSCDLRMGSGFCIdyalpsSGGSGSGISSPY 749
Cdd:cd22372     80 GGNLVgiLTSRNETGSQLLEN------QFYIKLTNG-TRRRRRSISENVTSCPYVSYGKFCI------KPDGSISTIVPQ 146
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  750 RFVTF-EP-FNVSfvndsvETVgglfeiQIPTNFTIAGHEEFIQTSSPKVTIDCSAFVCSNYAACHDLLSEYGTFCDNIN 827
Cdd:cd22372    147 ELETFvAPlLNVT------ENV------LIPNSFNLTVTDEYIQTRMDKVQINCLQYVCGNSLECRKLFQQYGPVCDNIL 214
                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  828 SILNEVNDLLDITQLQVANAlmqgvTLSSNLNTNLHSDVDNIDF-KSLLgcLGSQCGSSSRSLLEDLLFNKVKLSDVGFV 906
Cdd:cd22372    215 SIVNSVNQKEDMELLSFYSS-----TKPGGFNTPVFNNVSTGGFnISLL--LPPPSSPQGRSFIEDLLFTKVETVGLPTD 287
                          330       340       350       360       370       380       390       400
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  907 EAYNNCTGG--SEIRDLLCVQSFNGIKVLPPILSETQISGYTtAATVAAM-FPPWSAAAGVPFSLNVQYRINGLGVTMDV 983
Cdd:cd22372    288 DAYKKCTAGplGFLKDLVCAQEYNGLLVLPPIITAEMQTMYT-GSLVASMaFGGITAAGAIPFATQIQARINHLGITQSL 366
                          410       420       430       440       450       460       470       480
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  984 LNKNQKLIANAFNKALLSIQNGFTATNSALAKIQSVVNANAQALNSLLQQLFNKFGAISSSLQEILSRLDNLEAQVQIDR 1063
Cdd:cd22372    367 LLKNQEKIAASFNKAIGHMQEGFRSTSLALQQIQDVVNKQSAILTETMASLNKNFGAISSVIQDIYQQLDAIQADAQVDR 446
                          490       500       510       520       530       540       550       560
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797 1064 LINGRLTALNAYVSQQLSDitLIKAGASR--AIEKVNECVKSQSPRINFCGNGNHILSLVQNAPYGLLFIHFSYKPTSFK 1141
Cdd:cd22372    447 LITGRLSSLSVLASAKQAE--YYKVSQQRelATQKINECVKSQSNRYGFCGNGRHVLTIPQNAPNGIVFIHFTYTPESFV 524
                          570       580       590       600       610       620       630       640
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797 1142 TVLVSPGLCLSGDRG----IAPK--QGYFIKQNDSWMFTGSSYYYPEPISDKNVVFMNSCSVNFTkapfiYLNNSI---- 1211
Cdd:cd22372    525 NVTAIVGFCVNPANGsqyaIVPAngRGIFIQVNGTYYITARDMYMPRDITAGDIVTLTSCQANYV-----SVNKTVittf 599
                          650       660       670       680       690
                   ....*....|....*....|....*....|....*....|....*....|....*..
gi 1002351797 1212 --PNLSDFEAELSLWFKNHTSIAPNL-TFNSHInaTFLDLYYEMNVIQESIKSLNGS 1265
Cdd:cd22372    600 vdNDDFDFDDELSKWWNETKHELPDFdQFNYTI--PILNISNEIDRIQEVIQGLNDS 654
SARS-CoV-like_Spike_SD1-2_S1-S2_S2 cd22378
SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) ...
613-1265 2.23e-134

SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from SARS-CoV-2 (COVID-19) and related betacoronaviruses in the B lineage; This group contains the SD-1 and SD-2 subdomains of the S1 subunit C-terminal domain (C-domain), the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from betacoronaviruses in the sarbecovirus subgenus (B lineage), including highly pathogenic human CoVs such as Severe acute respiratory syndrome (SARS) coronavirus (SARS-CoV), and SARS-CoV-2 (also known as a 2019 novel coronavirus or 2019-nCoV). The CoV S protein is an envelope glycoprotein that plays a very important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains the coronavirus fusion machinery and is primarily alpha-helical. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-domain. The S1 C-domain also contains two subdomains (SD-1 and SD-2), which connect the S1 and S2 subunits. Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBD of mouse hepatitis virus (MHV) is located at the NTD, most CoVs, including SARS-CoV-2, SARS-CoV and MERS-CoV use the C-domain to bind their receptors. The S2 subunit comprises the fusion peptide (FP), a second proteolytic site (S2'), followed by an internal fusion peptide (IFP) and two heptad-repeat domains (HR1 and HR2) preceding the transmembrane domain (TM). After binding of the S1 subunit RBD on the virion to its receptor on the target cell, the HR1 and HR2 domains interact with each other to form a six-helix bundle (6-HB) fusion core, bringing viral and cellular membranes into close proximity for fusion and infection. In order to catalyze the membrane fusion reaction, CoV S needs to be primed through cleavage at the S1/S2 and S2' sites. Notably, SARS-CoV-2 has a functional polybasic (furin) cleavage site through the insertion of PRRAR*SV (* indicates the cleavage site) at the S1/S2 interface, which is absent in SARS-CoV and other SARS-related coronaviruses. The region modeled in this cd (SD-1 and SD-2, the S1/S2 cleavage region, and the S2 fusion subunit) plays an essential role in viral entry by initiating fusion of the viral and cellular membranes.


Pssm-ID: 411965 [Multi-domain]  Cd Length: 662  Bit Score: 426.72  E-value: 2.23e-134
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  613 GITGQGIFKEvSAAYYNNWQNLLYDSNGNIIGFKDFLTNKTYTILPCYSGRVSAAF--YQNSSSPALLYRNLKCSYVLNN 690
Cdd:cd22378      3 GLTGTGVLTP-SSKRFQPFQQFGRDVSDFTDSVRDPKTLEILDISPCSFGGVSVITpgTNASSEVAVLYQDVNCTDVPTA 81
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  691 IS----------FISQPFYFDSYLGCVLNAVNL-TSYSvssCDLRMGSGFCIDYALPSSGGSGSGIS-SPYRFVTFEPFN 758
Cdd:cd22378     82 IHadqltpawrvYSTGSNVFQTQAGCLIGAEHVnTSYE---CDIPIGAGICASYHTVSLLRSTSQKSiVAYTMSLGAENS 158
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  759 VSFVNDSvetvgglfeIQIPTNFTIAGHEEFIQTSSPKVTIDCSAFVCSNYAACHDLLSEYGTFCDNINSILNEVNDLLD 838
Cdd:cd22378    159 IAYSNNS---------IAIPTNFSISVTTEVMPVSMAKTSVDCTMYICGDSTECSNLLLQYGSFCTQLNRALSGIAVEQD 229
                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  839 ITQLQVAnALMQGVTLSSNLNtnlhsDVDNIDFKSLLGclgSQCGSSSRSLLEDLLFNKVKLSDVGFVEAYNNCTGGSEI 918
Cdd:cd22378    230 KNTQEVF-AQVKQMYKTPTIK-----DFGGFNFSQILP---DPSKPTKRSFIEDLLFNKVTLADAGFMKQYGDCLGDINA 300
                          330       340       350       360       370       380       390       400
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  919 RDLLCVQSFNGIKVLPPILSETQISGYTTAATVAAMFPPWSAAAG----VPFSLNVQYRINGLGVTMDVLNKNQKLIANA 994
Cdd:cd22378    301 RDLICAQKFNGLTVLPPLLTDEMIAAYTAALVSGTATAGWTFGAGaalqIPFAMQMAYRFNGIGVTQNVLYENQKQIANQ 380
                          410       420       430       440       450       460       470       480
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  995 FNKALLSIQNGFTATNSALAKIQSVVNANAQALNSLLQQLFNKFGAISSSLQEILSRLDNLEAQVQIDRLINGRLTALNA 1074
Cdd:cd22378    381 FNKAISQIQESLTTTSTALGKLQDVVNQNAQALNTLVKQLSSNFGAISSVLNDILSRLDKVEAEVQIDRLITGRLQSLQT 460
                          490       500       510       520       530       540       550       560
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797 1075 YVSQQLSDITLIKAGASRAIEKVNECVKSQSPRINFCGNGNHILSLVQNAPYGLLFIHFSYKPTSFKTVLVSPGLCLSGd 1154
Cdd:cd22378    461 YVTQQLIRAAEIRASANLAATKMSECVLGQSKRVDFCGKGYHLMSFPQAAPHGVVFLHVTYVPSQERNFTTAPAICHEG- 539
                          570       580       590       600       610       620       630       640
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797 1155 RGIAPKQGYFIKQNDSWMFTGSSYYYPEPISDKNVVFMNSCSVNFTkapfiYLNNSI-----PNLSDFEAELSLWFKNHT 1229
Cdd:cd22378    540 KAYFPREGVFVSNGTSWFITQRNFYSPQIITTDNTFVSGNCDVVIG-----IINNTVydplqPELDSFKEELDKYFKNHT 614
                          650       660       670
                   ....*....|....*....|....*....|....*.
gi 1002351797 1230 SIAPNLTFNSHINATFLDLYYEMNVIQESIKSLNGS 1265
Cdd:cd22378    615 SPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNES 650
MHV-like_Spike_S1_RBD cd21484
receptor-binding domain of the S1 subunit of the Spike (S) protein from mouse hepatitis virus ...
294-594 6.05e-131

receptor-binding domain of the S1 subunit of the Spike (S) protein from mouse hepatitis virus and other rodent coronaviruses; This group contains the receptor-binding domain (RBD) of the S1 subunit of the spike (S) protein from mouse hepatitis virus (MHV) and other rodent coronaviruses. MHV is the most common viral pathogen in contemporary laboratory mouse colonies manifesting as a primary infection in the upper respiratory tract. The CoV S protein is an envelope glycoprotein that plays the most important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains a hydrophobic fusion peptide and two heptad repeat regions. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-terminal domain (C-domain). Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). MHV uses mouse carcinoembryonic antigen related cell adhesion molecule 1a (mCEACAM1a) as the receptor; the RBD of MHV is located at the NTD. Most CoVs, such as SARS-CoV and MERS-CoV, use the C-domain to bind their receptors. Due to the key role of the S protein RBD in viral attachment, it is the major target for antibody-mediated neutralization. This model corresponds to the S1 subunit C-domain that serves as the RBD for most CoVs.


Pssm-ID: 394831  Cd Length: 264  Bit Score: 402.72  E-value: 6.05e-131
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  294 SGFTVKPVATVYRRIPNLPDCDIDNWLNNVSVPSPLNWERRIFSNCNFNLSTLLRLVHVDSFSCNNLDKSKIFGSCFNSI 373
Cdd:cd21484      1 SGYTVQPVGVVYRRVPNLPDCKIEEWLTAKSVPSPLNWERKTFQNCNFNLSSLLRYVQAESLSCNNIDASKVYGMCFGSI 80
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  374 TVDKFAIPNRRRDDLQLGSSGFLQSSNYKIDISSSSCQLYYSLPLVNVTINNFNPSSWNRRYGF---GSFNLSSYDVVYS 450
Cdd:cd21484     81 SIDKFAIPNSRRVDLQLGNSGFLQSFNYKIDTRATSCQLYYSLAQNNVTVNNHNPSSWNRRYGFndvATFGKGKHDVAYA 160
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  451 DHCFSVNSDFCPCADPSVVNSCAKSKPPSaicpagtkyrhcdldttlyvknwcrcsclpdpistyspntCPQKKVVVGIG 530
Cdd:cd21484    161 QQCFTVGASYCPCAQPSIVSPCTTDKPKR----------------------------------------CLQGDSCLGVG 200
                          250       260       270       280       290       300
                   ....*....|....*....|....*....|....*....|....*....|....*....|....
gi 1002351797  531 EHCPGLGINEEKCGtqlNHSSCFCSPDAFLGWSFDSCISNNRCNIFSNFIFNGINSGTTCSNDL 594
Cdd:cd21484    201 DHCDGLGVLEDKCG---GSNGCNCAADAFVGWSHDSCLSNGRCQIFANLLLNGINSGTTCSTDL 261
HCoV-OC43-like_Spike_S1_RBD cd21485
receptor-binding domain of the S1 subunit of the Spike (S) protein from human coronavirus OC43 ...
294-594 1.19e-124

receptor-binding domain of the S1 subunit of the Spike (S) protein from human coronavirus OC43 and related proteins; This group contains the receptor-binding domain (RBD) of the S1 subunit of the spike (S) protein from several betacoronaviruses including human coronavirus OC43 (HCoV-OC43) and bovine respiratory coronavirus (BCoV), among others. HCoV-OC43 is of zoonotic origin and is endemic in the human population, causing mild respiratory tract infections and possible severe complications or fatalities in young children, the elderly, and immunocompromised individuals. These viruses are related to the zoonotic SARS and MERS betacoronaviruses, which have high fatality rates and pandemic potential. The CoV S protein is an envelope glycoprotein that plays the most important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains a hydrophobic fusion peptide and two heptad repeat regions. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-terminal domain (C-domain). Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBD of mouse hepatitis virus (MHV) is located at the NTD, most CoVs use the C-domain to bind their receptors. It has been reported that HCoV-OC43 uses 9-O-acetyl-sialic acid (9-O-Ac-Sia) as a receptor, which is terminally linked to oligosaccharides decorating glycoproteins and gangliosides at the host cell surface. HCoV-OC43 appears to bind 9-O-Ac-Sia at the NTD. Due to the key role of the S protein RBD in viral attachment, it is the major target for antibody-mediated neutralization. This model corresponds to the S1 subunit C-domain that serves as the RBD for most CoVs.


Pssm-ID: 394832  Cd Length: 312  Bit Score: 387.83  E-value: 1.19e-124
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  294 SGFTVKPVATVYRRIPNLPDCDIDNWLNNVSVPSPLNWERRIFSNCNFNLSTLLRLVHVDSFSCNNLDKSKIFGSCFNSI 373
Cdd:cd21485      1 NGYTVQPIADVYRRIPNLPDCNIEAWLNDKSVPSPLNWERKTFSNCNFNMSSLMSFIQADSFTCNNIDAAKIYGMCFSSI 80
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  374 TVDKFAIPNRRRDDLQLGSSGFLQSSNYKIDISSSSCQLYYSLPLVNVTINNFNPSSWNRRYGF-----------GSFnl 442
Cdd:cd21485     81 TIDKFAIPNGRKVDLQLGNLGYLQSFNYRIDTTATSCQLYYNLPAANVSVSRFNPSTWNRRFGFteqsvfkpqpaGVF-- 158
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  443 SSYDVVYSDHCFSVNSDFCPCA-DPSVvnsCAKSKPPS---------AICPAGTKYRHCdldttlYVKNWCRCSCLPDPI 512
Cdd:cd21485    159 TDHDVVYAQHCFKAPTNFCPCKlDGSL---CVGSGPGIdagyknngiGTCPAGTNYLTC------HNLCQCDCLCTPDPI 229
                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  513 STYSPNT--CPQKKVVVGIGEHCPGLGINEEKCGTqlnhSSCFCSPDAFLGWSFDSCISNNRCNIFSNFIFNGINSGTTC 590
Cdd:cd21485    230 TSKATGPykCPQTKYLVGIGEHCSGLAIKSDYCGG----NPCTCQPQAFLGWSVDSCLQGDRCNIFANFILHDVNSGTTC 305

                   ....
gi 1002351797  591 SNDL 594
Cdd:cd21485    306 STDL 309
alphaCoV_Spike_SD1-2_S1-S2_S2 cd22369
SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) ...
600-1262 2.01e-118

SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) protein from alphacoronaviruses; This group contains the SD-1 and SD-2 subdomains of the S1 subunit C-terminal domain (C-domain), the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from alphacoronaviruses including human coronaviruses (HCoVs), HCoV-NL63, and HCoV-229E, and porcine coronaviruses, transmissible gastroenteritis virus (TGEV) and porcine epidemic diarrhea virus (PEDV), among others. The CoV S protein is an envelope glycoprotein that plays a very important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains the coronavirus fusion machinery and is primarily alpha-helical. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-domain. The S1 C-domain also contains two subdomains (SD-1 and SD-2), which connect the S1 and S2 subunits. Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBD of mouse hepatitis virus (MHV) is located at the NTD, most CoVs, including SARS-CoV-2, SARS-CoV and MERS-CoV use the C-domain to bind their receptors. The S2 subunit comprises the fusion peptide (FP), a second proteolytic site (S2'), followed by an internal fusion peptide (IFP), and two heptad-repeat domains (HR1 and HR2) preceding the transmembrane domain (TM). After binding of the S1 subunit RBD on the virion to its receptor on the target cell, the HR1 and HR2 domains interact with each other to form a six-helix bundle (6-HB) fusion core, bringing viral and cellular membranes into close proximity for fusion and infection. In order to catalyze the membrane fusion reaction, CoV S needs to be primed through cleavage at the S1/S2 and S2' sites. In the case of human-infecting coronaviruses such as SARS-CoV-2, HCoV-OC43, MERS-CoV, and HKU1 the spike protein contains an insertion of (R/K)-(2X)n-(R/K) (furin cleavage motif) at the S1/S2 site, which is absent in SARS-CoV and other SARS-related coronaviruses, as well as Rousettus bat coronavirus HKU9. The region modeled in this cd (SD-1 and SD-2, the S1/S2 cleavage region, and the S2 fusion subunit) plays an essential role in viral entry by initiating fusion of the viral and cellular membranes.


Pssm-ID: 411956 [Multi-domain]  Cd Length: 666  Bit Score: 383.95  E-value: 2.01e-118
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  600 EISTGVCVNYDLYGITGQGIFKEVSAAYYNNwqnLLYDSN-GNIIGFKDFLTNKTYTILPCySGRVSAAFYQN------S 672
Cdd:cd22369      4 VVHLNVCTDYTIYGITGRGIIRKSNSTYIAG---LYYTSNsGQLLGFKNSTTGEVFSVTPC-QLSSQVAVVSDnivgvmS 79
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  673 SSPALlyrnlkcSYVLNNIsfISQP-FYFDSylgcvlNAVNLTSYSVsscdLRMGS-GFCIDYALpssggsgsgisspyr 750
Cdd:cd22369     80 ATNNV-------SLGFNNT--IETPsFYYHS------NGAENCTEPV----LTYGSiGVCADGSI--------------- 125
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  751 fVTFEPFNVSFVNDSVETVGglfEIQIPTNFTIAGHEEFIQTSSPKVTIDCSAFVCSNYAACHDLLSEYGTFCDNINSIL 830
Cdd:cd22369    126 -TEVTPRSVSPEPVSPIITG---NISIPSNFTVSVQVEYLQMYLKPVSVDCSTYVCNGNPRCLQLLTQYASACRTIEEAL 201
                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  831 --------NEVNDLLDITQlqvaNALMQGVTLSSNlntnlhsdvDNIDFKSLLGClgsqcGSSSRSLLEDLLFNKVKLSD 902
Cdd:cd22369    202 qlsarlesVEVNSMITVSE----EALRLANISTFF---------DDYNLSAVLPA-----GVGGRSAIEDLLFDKVVTSG 263
                          330       340       350       360       370       380       390       400
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  903 VGFVEA-YNNCTGGSEI--RDLLCVQSFNGIKVLPPILSETQISGYTTAATVAAMFPPWSAAAGVPFSLNVQYRINGLGV 979
Cdd:cd22369    264 LGTVDEdYKACTKGLGIaaADVACAQYYNGIMVLPGVVDAEKMALYTASLTGGMVLGGFTAAAAIPFSLAVQSRLNYVAL 343
                          410       420       430       440       450       460       470       480
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  980 TMDVLNKNQKLIANAFNKALLSIQNGFTATN--------------SALAKIQSVVNANAQALNSLLQQLFNKFGAISSSL 1045
Cdd:cd22369    344 QTDVLQRNQQILANSFNSAMGNITVAFSEVNdaiqqtsdaintvaQALNKVQNVVNEQGQALSQLTKQLASNFQAISSSI 423
                          490       500       510       520       530       540       550       560
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797 1046 QEILSRLDNLEAQVQIDRLINGRLTALNAYVSQQLSDITLIKAGASRAIEKVNECVKSQSPRINFCGNGNHILSLVQNAP 1125
Cdd:cd22369    424 EDIYNRLDGLAADAQVDRLITGRLAALNAFVTQTLTKYTEVRASRQLAQQKINECVKSQSSRYGFCGNGTHLFSIVNAAP 503
                          570       580       590       600       610       620       630       640
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797 1126 YGLLFIHFSYKPTSFKTVLVSPGLCLSGDRGI--APKQGYFIKQNDSWMFTGSSYYYP-EP-ISDknVVFMNSCSVNFTK 1201
Cdd:cd22369    504 DGIMFLHTVLLPTEYVTVAAWAGLCVDGKAYVlrDDVVLTLFKLNDKYYVTPRDMFEPrVPvSSD--FVQISNCNVTYVN 581
                          650       660       670       680       690       700
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 1002351797 1202 APFIYLNNSIPN-------LSDFEAELSlwfkNHTsiAPNLTFNSHiNATFLDLYYEMNVIQESIKSL 1262
Cdd:cd22369    582 ITSDELPEVIPDyidvnktLEEFLANLP----NYT--LPDLPLDIF-NATYLNLTGEIADLENKSESL 642
HKU1-like_CoV_Spike_S1_RBD cd21478
receptor-binding domain of the S1 subunit of the Spike (S) protein from human coronavirus HKU1 ...
294-597 3.29e-117

receptor-binding domain of the S1 subunit of the Spike (S) protein from human coronavirus HKU1 and related coronaviruses; This family contains the receptor-binding domain (RBD) of the S1 subunit of the spike (S) protein from human coronavirus (CoV) HKU1, human coronavirus OC43 (HCoV-OC43), mouse hepatitis virus (MHV), porcine hemagglutinating encephalomyelitis virus (HEV), and other related coronaviruses. HKU1 is a human betacoronavirus that causes mild yet prevalent respiratory disease. HCoV-OC43 is of zoonotic origin and is endemic in the human population, causing mild respiratory tract infections and possible severe complications or fatalities in young children, the elderly, and immunocompromised individuals. MHV is the most common viral pathogen in contemporary laboratory mouse colonies manifesting as a primary infection in the upper respiratory tract. Porcine HEV is associated with acute outbreaks of wasting and encephalitis in nursing piglets from pig farms. These viruses are related to the zoonotic SARS and MERS betacoronaviruses, which have high fatality rates and pandemic potential. The CoV S protein is an envelope glycoprotein that plays the most important role in viral attachment, fusion and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains a hydrophobic fusion peptide and two heptad repeat regions. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-terminal domain (C-domain). Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBDs of MHV and HCoV-OC43 are located at the NTD, most CoVs use the C-domain to bind their receptors. Although a protein receptor has not yet been identified for HKU1, antibodies against the C-domain, but not those against the NTD, blocked HKU1 infection of cells, suggesting that the S1 C-domain is the primary HKU1 receptor-binding site. Due to the key role of the S protein RBD in viral attachment, it is the major target for antibody-mediated neutralization. This model corresponds to the S1 subunit C-domain that serves as the RBD for most CoVs.


Pssm-ID: 394825  Cd Length: 223  Bit Score: 364.09  E-value: 3.29e-117
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  294 SGFTVKPVATVYRRIPNLPDCDIDNWLNNVSVPSPLNWERRIFSNCNFNLSTLLRLVHVDSFSCNNLDKSKIFGSCFNSI 373
Cdd:cd21478      1 TGYTVQPIADVYRRIPNLPDCDIEEWLNAPTVPSPLNWERKTFSNCNFNMSSLLSLVQADSFSCNNIDASKIYGMCFGSI 80
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  374 TVDKFAIPNRRRDDLQLGSSGFLQSSNYKIDISSSSCQLYYSLPLVNVTINNFNPSSWNRRYGFGSF------NLSSYDV 447
Cdd:cd21478     81 TIDKFAIPNSRKVDLQLGSSGYLQSFNYRIDTAATSCQLYYSLPANNVTVTNFNPSSWNRRYGFNEFkpkpagNLGNHDV 160
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  448 VYSDHCFSVNSDFCPCAdpsvvnscakskppsaicpagtkyrhcdldttlyvknwcrcsclpdpistyspntcpqkkvvv 527
Cdd:cd21478    161 VYSQQCFNVPNTYCPCK--------------------------------------------------------------- 177
                          250       260       270       280       290       300       310
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  528 gigehcpglgineekcgtqlnhssCFCSPDAFLGWSFDSCISNNRCNIFSNFIFNGINSGTTCSNDLLYS 597
Cdd:cd21478    178 ------------------------CSCYPNAFLGWSADSCLSNGRCNIFANFILNGVNSGTTCSTDLQKP 223
CoV_Spike_S1_NTD cd21527
N-terminal domain of the S1 subunit of coronavirus Spike (S) proteins; This family contains ...
21-280 4.68e-114

N-terminal domain of the S1 subunit of coronavirus Spike (S) proteins; This family contains the N-terminal domain (NTD) of the S1 subunit of coronavirus (CoV) Spike (S) proteins from all four (A-D) lineages of betacoronaviruses, including three highly pathogenic human CoVs (HCoV) such as Middle East respiratory syndrome (MERS)-related CoV, Severe acute respiratory syndrome (SARS) CoV, and SARS-CoV-2, also known as a 2019 novel coronavirus (2019-nCoV) or COVID-19 virus. The CoV S protein is an envelope glycoprotein that plays the most important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains a hydrophobic fusion peptide and two heptad repeat regions. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-terminal domain (C-domain). Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). Most CoVs, including SARS-CoV-2, SARS-CoV and MERS-CoV, use the C-domain to bind their receptors. However, some CoVs from the A lineage, such as mouse hepatitis virus (MHV) uses the NTD to bind its receptor, mouse carcinoembryonic antigen related cell adhesion molecule 1a (mCEACAM1a). Bovine CoV and HCoV-OC43, also from the A lineage, recognize a sugar moiety, 5-N-acetyl-9-O-acetylneuraminic acid (Neu5,9Ac2), on cell-surface glycoproteins or glycolipids; this binding is also through the S1 NTD. The S1 NTD has also been the target for neutralizing antibodies, including human antibody CDC2-A2, and murine antibodies G2 and 5F9, which target MERS-CoV NTD. In addition, the S1 NTD contributes to the Spike trimer interface.


Pssm-ID: 394949  Cd Length: 268  Bit Score: 357.56  E-value: 4.68e-114
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797   21 RISEDVVDVSLGLGTYYVLNRVYLNTTLLFTGYFPKSGANFRDLALKGSIYLSTLWYKPPFLSDFNNGIFSKVKNTKLYV 100
Cdd:cd21527      1 KISTHTSDVSKGLGTYYPDDRVYSNTTLLLQGLFPYDGSNFTNYALKGSHALGTLWFYPPFVSPFNNGIFVKVKNTKNST 80
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  101 NNTLYSEFSTIVIGSVFVNTSYTIVVQPHNG--ILEITACQYTMCEYPHTVCKSKGSIRNE--SWHIDSSEPLCLFKKNF 176
Cdd:cd21527     81 SATIYSEYPAIVFGSTFGNTSYTVVIQPDNGgtLLEASACQYEMCEYNATICVPKTDGSDGnySWHIDSNAFNCTFEYNF 160
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  177 TYNVSADWLYFHFYQERGVFYAYYADV----GMPTTFLFSLYLGTILSHYYVMPLTCNAISSNTDNETLEYWVTPLSRRQ 252
Cdd:cd21527    161 TYNVNADLLYFGFYQEDGTLYAYYSDYvdlyGGPLKFLFSLPLGDNLTNYYVIPLTCRSIQSSDRKFAAAYYVTYLTPRT 240
                          250       260
                   ....*....|....*....|....*...
gi 1002351797  253 YLLNFDEHGVITNAVDCSSSFLSEIQCK 280
Cdd:cd21527    241 FLLNFDENGVITNAVDCSSNFLSELKCS 268
delta-PDCoV-like_Spike_SD1-2_S1-S2_S2 cd22373
SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) ...
604-1262 3.35e-113

SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from porcine coronavirus HKU15, avian coronaviruses, and related deltacoronaviruses; This group contains the SD-1 and SD-2 subdomains of the S1 subunit C-terminal domain (C-domain), the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from porcine coronavirus PDCoV, and several avian coronaviruses such as quail deltacoronavirus (QdCoV) UAE-HKU30, white-eye coronavirus HKU16, common moorhen coronavirus HKU21, thrush CoV HKU12, and munia CoV HKU13, all from the Buldecovirus subgenus of deltacoronaviruses. The CoV S protein is an envelope glycoprotein that plays a very important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains the coronavirus fusion machinery and is primarily alpha-helical. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-domain. The S1 C-domain also contains two subdomains (SD-1 and SD-2), which connect the S1 and S2 subunits. Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBD of mouse hepatitis virus (MHV) is located at the NTD, most CoVs, including SARS-CoV-2, SARS-CoV and MERS-CoV use the C-domain to bind their receptors. The S2 subunit comprises the fusion peptide (FP), a second proteolytic site (S2'), followed by an internal fusion peptide (IFP) and two heptad-repeat domains (HR1 and HR2) preceding the transmembrane domain (TM). After binding of the S1 subunit RBD on the virion to its receptor on the target cell, the HR1 and HR2 domains interact with each other to form a six-helix bundle (6-HB) fusion core, bringing viral and cellular membranes into close proximity for fusion and infection. In order to catalyze the membrane fusion reaction, CoV S needs to be primed through cleavage at the S1/S2 and S2' sites. In the case of human-infecting coronaviruses such as SARS-CoV-2, HCoV-OC43, MERS-CoV, and HCoV-KU1, the spike protein contains an insertion of (R/K)-(2X)n-(R/K) (furin cleavage motif) at the S1/S2 site, which is absent in SARS-CoV and other SARS-related coronaviruses, as well as Ro-BatCoV HKU9. The region modeled in this cd (SD-1 and SD-2, the S1/S2 cleavage region, and the S2 fusion subunit) plays an essential role in viral entry by initiating fusion of the viral and cellular membranes.


Pssm-ID: 411960 [Multi-domain]  Cd Length: 648  Bit Score: 369.55  E-value: 3.35e-113
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  604 GVCVNYDLYGITGQGIFKEVSAAYYNNwqnLLYDS-NGNIIGFKDFLTNKTYTILPCYSGRvSAAFYQNSSSPALLYRNl 682
Cdd:cd22373      1 DVCTDYTIYGVSGTGIIKPSDLQLHNG---IAFTSpTGELYAFKNITTGKTYQVLPCETPS-QLIVINNTIVGAITSSN- 75
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  683 kcSYVLNNISFISQP-FYFDSylgcvlnavNLTSYSVSSCDLRMGS-GFCIDYALpssggsgsgisspyrfvtfepFNVS 760
Cdd:cd22373     76 --STENGFTTTIVTPtFYYST---------NATSFNCTKPVLSYGPiSVCSDGAI---------------------VGTS 123
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  761 FVNDSVETVGGLF--EIQIPTNFTIAGHEEFIQTSSPKVTIDCSAFVCSNYAACHDLLSEYGTFCDNINSILNEVNDLLD 838
Cdd:cd22373    124 TLQDTRPSIVSLYdgEVEIPSAFTLSVQTEYLQVQAEQVVVDCPQYVCNGNSRCLQLLAQYTSACSNIESALHSSAQLDS 203
                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  839 ITQLQVANALMQGVTLSsNLnTNLHSDvdnIDFKSLLGCLGSqcgssSRSLLEDLLFNKVKLSDVGFVEA-YNNCTGGSE 917
Cdd:cd22373    204 REITNMFQTSTQSLELA-NI-TNFKGD---YNFTSILTTKIG-----GRSAIEDLLFNKVVTNGLGTVDQdYKSCSKDMA 273
                          330       340       350       360       370       380       390       400
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  918 IRDLLCVQSFNGIKVLPPILSETQISGYTTAATVAAMFPPWSAAAGVPFSLNVQYRINGLGVTMDVLNKNQKLIANAFNK 997
Cdd:cd22373    274 IADLVCSQYYNGIMVLPGVVDAEKMAMYTGSLTGAMVFGGLTAAAAIPFSTAVQARLNYVALQTNVLQENQKILAESFNQ 353
                          410       420       430       440       450       460       470       480
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  998 ALLSIQNGFTATNSALA--------------KIQSVVNANAQALNSLLQQLFNKFGAISSSLQEILSRLDNLEAQVQIDR 1063
Cdd:cd22373    354 AVGNISLALSSVNDAIQqtsealntvanainKIQTVVNQQGEALSHLTAQLSNNFQAISTSIQDIYNRLDEVEANQQVDR 433
                          490       500       510       520       530       540       550       560
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797 1064 LINGRLTALNAYVSQQLSDITLIKAGASRAIEKVNECVKSQSPRINFCGNGNHILSLVQNAPYGLLFIHFSYKPTSFKTV 1143
Cdd:cd22373    434 LITGRLAALNAYVTQLLNQMSQIRQSRLLAQQKINECVKSQSSRYGFCGNGTHLFSITQAAPNGIFFMHAVLVPTKFTRV 513
                          570       580       590       600       610       620       630       640
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797 1144 LVSPGLCLSGDRGIAPK-QGYFIKQNDSWMFTGSSYYYPEPISDKNVVFMNSCSVNFTKAPFIYLNNSIPNLSDFEAELS 1222
Cdd:cd22373    514 NASAGICVDNTKGYSLQpQLILYQFNNSWRVTPRNMYEPRLPRQADFIPLTDCSVTFYNTTAADLPNIIPDYVDVNQTVS 593
                          650       660       670       680
                   ....*....|....*....|....*....|....*....|
gi 1002351797 1223 LWFKNHTSIAPNLTFNSHINATFLDLYYEMNVIQESIKSL 1262
Cdd:cd22373    594 DIIDNLPTPTPPQLDVDIYNNTILNLTQEINDLQERSKNL 633
HEV_Spike_S1_RBD cd21508
receptor-binding domain of the S1 subunit of the Spike (S) protein from porcine ...
294-594 4.36e-110

receptor-binding domain of the S1 subunit of the Spike (S) protein from porcine hemagglutinating encephalomyelitis virus; This group contains the receptor-binding domain (RBD) of the S1 subunit of the spike (S) protein from porcine hemagglutinating encephalomyelitis virus (HEV), which is associated with acute outbreaks of wasting and encephalitis in nursing piglets from pig farms. Porcine HEV is related to the zoonotic SARS and MERS betacoronaviruses, which have high fatality rates and pandemic potential. The CoV S protein is an envelope glycoprotein that plays the most important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains a hydrophobic fusion peptide and two heptad repeat regions. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-terminal domain (C-domain). Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBD of mouse hepatitis virus (MHV) is located at the NTD, most CoVs use the C-domain to bind their receptors. The protein receptor for porcine HEV has not yet been identified. Due to the key role of the S protein RBD in viral attachment, it is the major target for antibody-mediated neutralization. This model corresponds to the S1 subunit C-domain that serves as the RBD for most CoVs.


Pssm-ID: 394835  Cd Length: 298  Bit Score: 348.27  E-value: 4.36e-110
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  294 SGFTVKPVATVYRRIPNLPDCDIDNWLNNVSVPSPLNWERRIFSNCNFNLSTLLRLVHVDSFSCNNLDKSKIFGSCFNSI 373
Cdd:cd21508      1 NGYTVQPVATVYRRIPDLPNCDIEAWLNSKTVSSPLNWERKIFSNCNFNMGRLMSFIQADSFGCNNIDASRLYGMCFGSI 80
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  374 TVDKFAIPNRRRDDLQLGSSGFLQSSNYKIDISSSSCQLYYSLPLVNVTINNFNPSSWNRRYGFGSFNLSS---YDVVYS 450
Cdd:cd21508     81 TIDKFAIPNSRKVDLQVGKSGYLQSFNYKIDTAVSSCQLYYSLPAANVSVTHYNPSSWNRRYGFNNQSFGSrglHDAVYS 160
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  451 DHCFSVNSDFCPCADPSVVNSCAkskppSAICPAGTKYRHCDLDTTLYVKnwCRCSCLPDPISTYSPN--TCPQKKVVVG 528
Cdd:cd21508    161 QQCFNTPNTYCPCRTSQCIGGAG-----TGTCPVGTTVRKCFAAVTNATK--CTCWCQPDPSTYKGVNawTCPQSKVSIQ 233
                          250       260       270       280       290       300
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 1002351797  529 IGEHCPGLGINEEKCgtqlNHSSCFCSPDAFLGWSFDSCISNNRCNIFSNFIFNGINSGTTCSNDL 594
Cdd:cd21508    234 PGQHCPGLGLVEDDC----SGNPCTCKPQAFIGWSSETCLQNGRCNIFANFILNDVNSGTTCSTDL 295
HCoV-NL63-229E-like_Spike_SD1-2_S1-S2_S2 cd22375
SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) ...
606-1263 8.59e-102

SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoproteins from HCoV-NL63, HCoV-229E, and related alphacoronavirus; This group contains the SD-1 and SD-2 subdomains of the S1 subunit C-terminal domain (C-domain), the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from alphacoronaviruses, including human coronaviruses (HCoVs), HCoV-NL63 and HCoV-229E. The CoV S protein is an envelope glycoprotein that plays a very important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains the coronavirus fusion machinery and is primarily alpha-helical. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-domain. The S1 C-domain also contains two subdomains (SD-1 and SD-2), which connect the S1 and S2 subunits. Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBD of mouse hepatitis virus (MHV) is located at the NTD, most CoVs, including SARS-CoV-2, SARS-CoV and MERS-CoV use the C-domain to bind their receptors. The S2 subunit comprises the fusion peptide (FP), a second proteolytic site (S2'), followed by an internal fusion peptide (IFP) and two heptad-repeat domains (HR1 and HR2) preceding the transmembrane domain (TM). After binding of the S1 subunit RBD on the virion to its receptor on the target cell, the HR1 and HR2 domains interact with each other to form a six-helix bundle (6-HB) fusion core, bringing viral and cellular membranes into close proximity for fusion and infection. In order to catalyze the membrane fusion reaction, CoV S needs to be primed through cleavage at the S1/S2 and S2' sites. In the case of human-infecting coronaviruses such as SARS-CoV-2, HCoV-OC43, MERS-CoV, and HKU1, the spike protein contains an insertion of (R/K)-(2X)n-(R/K) (furin cleavage motif) at the S1/S2 site, which is absent in SARS-CoV and other SARS-related coronaviruses, as well as Rousettus bat coronavirus HKU9. The region modeled in this cd (SD-1 and SD-2, the S1/S2 cleavage region, and the S2 fusion subunit) plays an essential role in viral entry by initiating fusion of the viral and cellular membranes.


Pssm-ID: 411962 [Multi-domain]  Cd Length: 677  Bit Score: 339.19  E-value: 8.59e-102
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  606 CVNYDLYGITGQGIFKEVSAAYYNNwqnLLYDSN-GNIIGFKDFLTNKTYTILPCYSGRvSAAFYQNSSSPALLYRNlKC 684
Cdd:cd22375     10 CTKYNIYDYSGTGVIRSSNDSFIGG---ITYTSNsGNLLGFKDVSTGTIYSITPCNPPD-QVVVYQQAIVGAMLSEN-ET 84
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  685 SYVLNNISFISQPFYFDSYLGCVLNAVnlTSYSvsscdlrmGSGFCIDYALpssggsgsgisspyrfVTFEPFNVSFVND 764
Cdd:cd22375     85 RYGLSNVVELPNFYYASNGTYNCTDAV--LTYS--------NFGICADGSI----------------IPVRPRNVSDNGV 138
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  765 SVETVGGLfeiQIPTNFTIAGHEEFIQTSSPKVTIDCSAFVCSNYAACHDLLSEYGTFCDNINSIL--------NEVNDL 836
Cdd:cd22375    139 SAIVTANL---SIPSNWTTSVQVEYLQITSTPIVVDCSTYVCNGNPRCVELLKQYTSACKTIEDALrlsarlesADVSSM 215
                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  837 L--DITQLQVANalmqgvtLSSNLNTNLHSDVDNIDFksllgclgSQCGSSSRSLLEDLLFNKVKLSDVGFVEA-YNNCT 913
Cdd:cd22375    216 LtfDSNAFTLAN-------VSSFGDYNLSSVLPQLPT--------SGSRIAGRSAIEDLLFSKVVTSGLGTVDAdYKSCT 280
                          330       340       350       360       370       380       390       400
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  914 GGSEIRDLLCVQSFNGIKVLPPILSETQISGYTTAATVAAMFPPWSAAAGVPFSLNVQYRINGLGVTMDVLNKNQKLIAN 993
Cdd:cd22375    281 KGLSIADLACAQYYNGIMVLPGVADAERMAMYTGSLIGGMALGGLTSAAAIPFSLALQARLNYVALQTDVLQENQKILAA 360
                          410       420       430       440       450       460       470       480
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  994 AFNKALLSIQNGFTATN--------------SALAKIQSVVNANAQALNSLLQQLFNKFGAISSSLQEILSRLDNLEAQV 1059
Cdd:cd22375    361 SFNKAMTNIVDAFTGVNdaitqtsqaiqtvaTALNKIQDVVNQQGNALNHLTSQLRQNFQAISSSIQAIYDRLDTIQADQ 440
                          490       500       510       520       530       540       550       560
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797 1060 QIDRLINGRLTALNAYVSQQLSDITLIKAGASRAIEKVNECVKSQSPRINFCGNGNHILSLVQNAPYGLLFIHFSYKPTS 1139
Cdd:cd22375    441 QVDRLITGRLAALNAFVSQTLTKYTEVRASRQLAQQKVNECVKSQSNRYGFCGNGTHIFSIVNAAPEGLVFLHTVLLPTQ 520
                          570       580       590       600       610       620       630       640
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797 1140 FKTVLVSPGLCLSGDRGIAPKQGYFI--KQNDSWMFTGSSYYYPEPISDKNVVFMNSCSVNFTKAPFIYLNNSIPNLSDF 1217
Cdd:cd22375    521 YKDVEAWSGLCVDGVNGYVLRQPNLAlyKDGGVFRITSRVMFEPRIPTMADFVQIENCNVTFVNISRSELQTIVPEYVDV 600
                          650       660       670       680
                   ....*....|....*....|....*....|....*....|....*..
gi 1002351797 1218 EAELS-LWFKNHTSIAPNLTFNSHiNATFLDLYYEMNVIQESIKSLN 1263
Cdd:cd22375    601 NKTLQeLIEKLPNYTVPDLDLDQY-NQTILNLTSEISTLENKSAELN 646
alphaCoV-HKU2-like_Spike_SD1-2_S1-S2_S2 cd22371
SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the CoV ...
613-1263 1.73e-101

SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the CoV spike (S) glycoprotein from Rhinolophus bat coronavirus HKU2 and related alphacoronaviruses; This group contains the SD-1 and SD-2 subdomains of the S1 subunit C-terminal domain (C-domain), the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from Wencheng shrew coronavirus (WESV), Lucheng Rn rat coronavirus (LRNV), and two bat viruses (Rhinolophus bat coronavirus HKU2 and BtRf-AlphaCoV/YN2012). Members of this group form a distinct cluster that is separated from the other alphacoronaviruses. The CoV S protein is an envelope glycoprotein that plays a very important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains the coronavirus fusion machinery and is primarily alpha-helical. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-domain. The S1 C-domain also contains two subdomains (SD-1 and SD-2), which connect the S1 and S2 subunits. Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBD of mouse hepatitis virus (MHV) is located at the NTD, most CoVs, including SARS-CoV-2, SARS-CoV and MERS-CoV use the C-domain to bind their receptors. The S2 subunit comprises the fusion peptide (FP), a second proteolytic site (S2'), followed by an internal fusion peptide (IFP) and two heptad-repeat domains (HR1 and HR2) preceding the transmembrane domain (TM). After binding of the S1 subunit RBD on the virion to its receptor on the target cell, the HR1 and HR2 domains interact with each other to form a six-helix bundle (6-HB) fusion core, bringing viral and cellular membranes into close proximity for fusion and infection. In order to catalyze the membrane fusion reaction, CoV S needs to be primed through cleavage at the S1/S2 and S2' sites. In the case of human-infecting coronaviruses such as SARS-CoV-2, HCoV-OC43, MERS-CoV, and HCoV-KU1, the spike protein contains an insertion of (R/K)-(2X)n-(R/K) (furin cleavage motif) at the S1/S2 site, which is absent in SARS-CoV and other SARS-related coronaviruses, as well as Ro-BatCoV HKU9. The region modeled in this cd (SD-1 and SD-2, the S1/S2 cleavage region, and the S2 fusion subunit) plays an essential role in viral entry by initiating fusion of the viral and cellular membranes.


Pssm-ID: 411958 [Multi-domain]  Cd Length: 686  Bit Score: 338.69  E-value: 1.73e-101
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  613 GITGQGIFKEVSAAYYNNWQNLLYDSNGNIIGFKdfltNKTYTILPCYSGRVSAaFYQNSSSPALLYRNLKCSYVLNNIS 692
Cdd:cd22371      3 GVTFQGILYETNFTFDSFYNLLYKGSMVKYVRIL----GVVYEVEPCNEFSYSV-LKNNSSSYGTLYSGADCNQIDTKTF 77
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  693 FISQPFY--FDSYLGCVLNA--VNLTSYSvssCDLRMGSGFCIDYalpssggsgSGISSPYRFVTFEPFNvsfvNDSVET 768
Cdd:cd22371     78 RFKARSHtgTNTSLGCLFNAsyTNDTYTT---CLNPLGNGFCADV---------NVTSPVVGNIGIQKHD----TDYVRP 141
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  769 VGGLFEIQIPTNFTIAGHEEFIQTSSPKVTIDCSAFVCSNYAACHDLLSEYGTFCDNINSILNEVNDLLDITQLqvanAL 848
Cdd:cd22371    142 ILTEQFIELPLDHQLVVKEQFLQTSMPKFDVDCERYICDVSKACRELLFKYGGFCSKITADIKGSSILLDSQIL----GL 217
                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  849 MQGVTLSSnlnTNLHSDVDNIDFKSLLGclgsqcGSSSRSLLEDLLFNKVKLSDVGFVEAYNNCTGgSEIRDLLCVQSFN 928
Cdd:cd22371    218 YKTIAVDF---SSPDVDFGDFNFSMFMS------EKNGRSFIEDLLFDKIVTTGPGFYQDYYDCKK-MNLQDLTCAQYYN 287
                          330       340       350       360       370       380       390       400
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  929 GIKVLPPILSETQISGYTTAATVAAMFPPWSAAAG-VPFSLNVQYRINGLGVTMDVLNKNQKLIANAFNKALLSIQNGFT 1007
Cdd:cd22371    288 GIMVIPPIMDDETIGMYGGIVAASMTAGLFGGQAGmVTWNTAMAGRLNALGVTQDALVEDVNKLANGFNNLTQSVSKLAK 367
                          410       420       430       440       450       460       470       480
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797 1008 ATNSALAKIQSVVNANAQALNSLLQQLFNKFGAISSSLQEILSRLDNLEAQVQIDRLINGRLTALNAYVSQQLSDITLIK 1087
Cdd:cd22371    368 TTSQALSAIQAVVNQNAAQVEQLVQGLSENFGAISNNFEVIAERLEKLEADQQMDRLINGRMNVLQNFVTNYKLKISELK 447
                          490       500       510       520       530       540       550       560
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797 1088 AGASRAIEKVNECVKSQSPRINFCGNGNHILSLVQNAPYGLLFIHFSYKPTSFKTVLVSPGLCLSGDRGIAP---KQGYF 1164
Cdd:cd22371    448 STQRLVQSLINECVYAQSLRNGFCGDGLHVMSLMQNAPDGIMFFHYTLKPNNTIIVKTTPGLCLSNEVCIKPidaKFGVL 527
                          570       580       590       600       610       620       630       640
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797 1165 IKQNDS-WMFTGSSYYYPEPISDKNVVFMnSCSVNFTKapfiyLNNSI-----PNLSDFEAELSLWFKNHTS---IAPNL 1235
Cdd:cd22371    528 VSANDSyWHFTPRNIYNPENITNSNIIAV-SGGANYTT-----VNNTIdiiepPQNPPIDEEFRELYKNVTLeleQLKNI 601
                          650       660       670
                   ....*....|....*....|....*....|.
gi 1002351797 1236 TFnshiNATFLDLYYE---MNVIQESIKSLN 1263
Cdd:cd22371    602 TF----DMSKLNLTYEidrLNEIAENVSKLH 628
TGEV-like_Spike_SD1-2_S1-S2_S2 cd22377
SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) ...
604-1253 7.17e-99

SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from transmissible gastroenteritis virus and related alphacoronaviruses; This group contains the SD-1 and SD-2 subdomains of the S1 subunit C-terminal domain (C-domain), the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from porcine transmissible gastroenteritis virus (TGEV), canine coronavirus (CCoV), and feline coronavirus (FCoV). They display greater than 96% sequence identity and have been grouped in the same species, alphacoronavirus 1, within the Alphacoronavirus genus. The CoV S protein is an envelope glycoprotein that plays a very important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains the coronavirus fusion machinery and is primarily alpha-helical. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-domain. The S1 C-domain also contains two subdomains (SD-1 and SD-2), which connect the S1 and S2 subunits. Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBD of mouse hepatitis virus (MHV) is located at the NTD, most CoVs, including SARS-CoV-2, SARS-CoV and MERS-CoV use the C-domain to bind their receptors. The S2 subunit comprises the fusion peptide (FP), a second proteolytic site (S2'), followed by an internal fusion peptide (IFP) and two heptad-repeat domains (HR1 and HR2) preceding the transmembrane domain (TM). After binding of the S1 subunit RBD on the virion to its receptor on the target cell, the HR1 and HR2 domains interact with each other to form a six-helix bundle (6-HB) fusion core, bringing viral and cellular membranes into close proximity for fusion and infection. In order to catalyze the membrane fusion reaction, CoV S needs to be primed through cleavage at the S1/S2 and S2' sites. In the case of human-infecting coronaviruses such as SARS-CoV-2, HCoV-OC43, MERS-CoV, and HKU1, the spike protein contains an insertion of (R/K)-(2X)n-(R/K) (furin cleavage motif) at the S1/S2 site, which is absent in SARS-CoV and other SARS-related coronaviruses, as well as Rousettus bat coronavirus HKU9. The region modeled in this cd (SD-1 and SD-2, the S1/S2 cleavage region, and the S2 fusion subunit) plays an essential role in viral entry by initiating fusion of the viral and cellular membranes.


Pssm-ID: 411964 [Multi-domain]  Cd Length: 751  Bit Score: 333.27  E-value: 7.17e-99
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  604 GVCVNYDLYGITGQGIFKE-----VSAAYYNNwqnllydSNGNIIGFKDFLTNKTYTILPC--------YSGRVSAAFYQ 670
Cdd:cd22377      8 DECTDYNIYGFQGTGIIRNttsrlVAGLYYTS-------ISGDLLAFKNSTTGEIFTVVPCdltaqaavINDEIVGAITS 80
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  671 NSSSPALLYRNLKCSY-----VLNNISFISQP-FYFDSYLGcvlnavNLTSYSVSSCDLRMGSGFCIDYALpssggsgsg 744
Cdd:cd22377     81 VNQTDLFEFVNHTQSRrsrrsTLGLVHTYTMPqFYYITKWN------NDTSTNCTSVITYSSFAICNTGEI--------- 145
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  745 isspyRFVtfepfNVSFVNDSVETVGGLF-----EIQIPTNFTIAGHEEFIQTSSPKVTIDCSAFVCSNYAACHDLLSEY 819
Cdd:cd22377    146 -----KYV-----NVTHVEIVDDSIGVIKpistgNITIPKNFTVAVQAEYIQIQVKPVVVDCAKYVCNGNRHCLKLLTQY 215
                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  820 GTFCDNINSILN--------EVNDLLDITQLQVANALMQGVTLSSNLNTNLhsdvDNIDFKSLLGCLGSQCGSssRSLLE 891
Cdd:cd22377    216 TSACQTIENALNlgarleslMLNDMITVSDRSLELATVEKFNSTVLGGEKL----GGFYFDGLKDLLPPRIGK--RSAIE 289
                          330       340       350       360       370       380       390       400
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  892 DLLFNKVKLSDVGFV-EAYNNCTGGSEIRDLLCVQSFNGIKVLPPILSETQISGYTTAATVAAMFPPWSAAAGVPFSLNV 970
Cdd:cd22377    290 DLLFNKVVTSGLGTVdDDYKKCSAGTDVADLVCAQYYNGIMVLPGVVDDNKMAMYTASLIGGMALGSITSAVAVPFAMQV 369
                          410       420       430       440       450       460       470       480
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  971 QYRINGLGVTMDVLNKNQKLIANAFNKAL--------------LSIQNGFTATNSALAKIQSVVNANAQALNSLLQQLFN 1036
Cdd:cd22377    370 QARLNYVALQTDVLQENQKILANAFNNAIgnitlalgkvsnaiTTTSDGFNTMASALTKIQSVVNQQGEALSQLTSQLQK 449
                          490       500       510       520       530       540       550       560
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797 1037 KFGAISSSLQEILSRLDNLEAQVQIDRLINGRLTALNAYVSQQLSDITLIKAGASRAIEKVNECVKSQSPRINFCGNGNH 1116
Cdd:cd22377    450 NFQAISSSIAEIYNRLEKVEADAQVDRLITGRLAALNAYVSQTLTQYAEVKASRQLAMEKVNECVKSQSDRYGFCGNGTH 529
                          570       580       590       600       610       620       630       640
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797 1117 ILSLVQNAPYGLLFIHFSYKPTSFKTVLVSPGLCLS-GDRGIAPKQGYFIKQ-NDSWMFTGSSYYYPEPISDKNVVFMNS 1194
Cdd:cd22377    530 LFSLVNSAPDGLLFFHTVLLPTEWEEVTAWSGICVNdTYAYVLKDFLTSIFSyNGTYMVTPRNMFQPRKPQMSDFVQITS 609
                          650       660       670       680       690       700
                   ....*....|....*....|....*....|....*....|....*....|....*....|..
gi 1002351797 1195 CSVNFTKAPFIYLNNSIPNLSDFEAELS--LWFKNHTSIAPNLTFNSHI-NATFLDLYYEMN 1253
Cdd:cd22377    610 CEVTFLNTTYTTFQEIVIDYIDINKTIAdmLEQYNPNYTVPELDLQLEIfNQTKLNLTAEID 671
delta-PiCoV-like_Spike_SD1-2_S1-S2_S2 cd22374
SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) ...
599-1263 1.74e-98

SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from Pigeon coronavirus UAE-HKU29, and related avian deltacoronaviruses; This group contains the SD-1 and SD-2 subdomains of the S1 subunit C-terminal domain (C-domain), the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from Pigeon coronavirus UAE-HKU29, and related avian deltacoronaviruses including Falcon coronavirus UAE-HKU27, Magpie-robin coronavirus HKU18, Sparrow coronavirus HKU17, and Night heron coronavirus HKU19. The CoV S protein is an envelope glycoprotein that plays a very important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains the coronavirus fusion machinery and is primarily alpha-helical. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the (C-domain. The S1 C-domain also contains two subdomains (SD-1 and SD-2), which connect the S1 and S2 subunits. Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBD of mouse hepatitis virus (MHV) is located at the NTD, most CoVs, including SARS-CoV-2, SARS-CoV and MERS-CoV use the C-domain to bind their receptors. The S2 subunit comprises the fusion peptide (FP), a second proteolytic site (S2'), followed by an internal fusion peptide (IFP) and two heptad-repeat domains (HR1 and HR2) preceding the transmembrane domain (TM). After binding of the S1 subunit RBD on the virion to its receptor on the target cell, the HR1 and HR2 domains interact with each other to form a six-helix bundle (6-HB) fusion core, bringing viral and cellular membranes into close proximity for fusion and infection. In order to catalyze the membrane fusion reaction, CoV S needs to be primed through cleavage at the S1/S2 and S2' sites. In the case of human-infecting coronaviruses such as SARS-CoV-2, HCoV-OC43, MERS-CoV, and HCoV-KU1, the spike protein contains an insertion of (R/K)-(2X)n-(R/K) (furin cleavage motif) at the S1/S2 site, which is absent in SARS-CoV and other SARS-related coronaviruses, as well as Ro-BatCoV HKU9. The region modeled in this cd (SD-1 and SD-2, the S1/S2 cleavage region, and the S2 fusion subunit) plays an essential role in viral entry by initiating fusion of the viral and cellular membranes.


Pssm-ID: 411961 [Multi-domain]  Cd Length: 739  Bit Score: 331.85  E-value: 1.74e-98
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  599 TEIST---GVCVNYDLYGITGQGIFKEVSAAYYnnwQNLLYDS-NGNIIGFKDFLTNKTYTILPC--------YSGRVSA 666
Cdd:cd22374     18 TDISTvylDVCTKYNIYGKTGTGIIRLTNQSYI---AGLYYTSpSGDLLAFKNVTTQTVYSVTPCrlssqvavYNGSIIA 94
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  667 AFyqnSSSPALLYRNlkcsyvlNNISFISQPFYFDSYLGCVLNAVNLTSYSVSSCDlrmGSGFCIDYAlpssggsgsgis 746
Cdd:cd22374     95 AF---TSTENFTIAD-------FTYSRATPMFYYHSIGNDTCETPVITFGSIGVCP---GGGLHFVDP------------ 149
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  747 spyrfVTFEPFNVSFVNDSvetvgglfEIQIPTNFTIAGHEEFIQTSSPKVTIDCSAFVCSNYAACHDLLSEYGTFCDNI 826
Cdd:cd22374    150 -----TSNEFTNVVPISTQ--------NISIPKNFTVSIQTEYIQIEQQPVTVDCRQYVCNGNPRCLQLLMQYTSACSTI 216
                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  827 NSILNeVNDLLDITQLQVANALMQGVTLSSNLnTNLHSDVDNIDFKSLLgclgsQCGSSSRSLLEDLLFNKVKLSDVGFV 906
Cdd:cd22374    217 EQALS-LNARLEAASIQTMLTYSPETLKLANI-TNFQSDDVNYNLTNIL-----PKKYQGRSAIEDLLFDKVVTNGLGTV 289
                          330       340       350       360       370       380       390       400
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  907 EA-YNNCTGGSEIRDLLCVQSFNGIKVLPPILSETQISGYTTAATVAAMFPPWSAAAGVPFSLNVQYRINGLGVTMDVLN 985
Cdd:cd22374    290 DQdYKACTNGVSIADLVCAQYYNGIMVLPGVADPEKMAQYTASLTGGMVFGGLTSAAAIPFSLAVQSRLNYVALQTDVLQ 369
                          410       420       430       440       450       460       470       480
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  986 KNQKLIANAFNKALLSIQNGF--------------TATNSALAKIQSVVNANAQALNSLLQQLFNKFGAISSSLQEILSR 1051
Cdd:cd22374    370 QNQQILADSFNNAMGNITLAFkevseglsqvsgaiTTVANALTKIQTVVNSQGQALATLTEQLANNFQAISASIADIYNR 449
                          490       500       510       520       530       540       550       560
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797 1052 LDNLEAQVQIDRLINGRLTALNAYVSQQLSDITLIKAGASRAIEKVNECVKSQSPRINFCGNGNHILSLVQNAPYGLLFI 1131
Cdd:cd22374    450 LNQLEADAQVDRLITGRLAALNAFVTQTLSKLAEVRQARQLALDKINECVKSQSSRYGFCGNGTHLFSIVNAAPYGFVFF 529
                          570       580       590       600       610       620       630       640
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797 1132 HFSYKPTSFKTVLVSPGLCLSGdRGIAPK--QGYFIKQNDSWMFTGSSYYYPEPISDKNVVFMNSCSVNFTKAPFIYLNN 1209
Cdd:cd22374    530 HTVLLPTQYATVQAYSGICQNG-RALALKdpSLALFRGTDKYLVTPRNMYQPRTAAQADFVYIESCTVTYLNLTDTTIDA 608
                          650       660       670       680       690
                   ....*....|....*....|....*....|....*....|....*....|....*
gi 1002351797 1210 SIPNLSDFEAELSLWFKN-HTSIAPNLTFNsHINATFLDLYYEMNVIQESIKSLN 1263
Cdd:cd22374    609 VIPDYVDVNKTVEDILNNlPNYTKPDLDIG-RYNNTILNLTTEINDLNGRAENLS 662
PDEV-like_Spike_SD1-2_S1-2_S2 cd22376
SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) ...
599-1263 1.65e-97

SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from Porcine epidemic diarrhea virus and related alphacoronavirus; This group contains the SD-1 and SD-2 subdomains of the S1 subunit C-terminal domain (C-domain), the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from alphacoronaviruses, including porcine epidemic diarrhea virus (PEDV), Scotophilus bat coronavirus, and swine enteric coronavirus, among others. The CoV S protein is an envelope glycoprotein that plays a very important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains the coronavirus fusion machinery and is primarily alpha-helical. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-domain. The S1 C-domain also contains two subdomains (SD-1 and SD-2), which connect the S1 and S2 subunits. Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBD of mouse hepatitis virus (MHV) is located at the NTD, most CoVs, including SARS-CoV-2, SARS-CoV and MERS-CoV use the C-domain to bind their receptors. The S2 subunit comprises the fusion peptide (FP), a second proteolytic site (S2'), followed by an internal fusion peptide (IFP) and two heptad-repeat domains (HR1 and HR2) preceding the transmembrane domain (TM). After binding of the S1 subunit RBD on the virion to its receptor on the target cell, the HR1 and HR2 domains interact with each other to form a six-helix bundle (6-HB) fusion core, bringing viral and cellular membranes into close proximity for fusion and infection. In order to catalyze the membrane fusion reaction, CoV S needs to be primed through cleavage at the S1/S2 and S2' sites. In the case of human-infecting coronaviruses such as SARS-CoV-2, HCoV-OC43, MERS-CoV, and HKU1 the spike protein contains an insertion of (R/K)-(2X)n-(R/K) (furin cleavage motif) at the S1/S2 site, which is absent in SARS-CoV and other SARS-related coronaviruses, as well as Rousettus bat coronavirus HKU9. The region modeled in this cd (SD-1 and SD-2, the S1/S2 cleavage region, and the S2 fusion subunit) plays an essential role in viral entry by initiating fusion of the viral and cellular membranes.


Pssm-ID: 411963 [Multi-domain]  Cd Length: 673  Bit Score: 327.10  E-value: 1.65e-97
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  599 TEISTGVCVNYDLYGITGQGIFKE----VSAAYYnnwqnllYDSNGNIIGFKDFLTN-KTYTILPCySGRVSAAFYQN-- 671
Cdd:cd22376      3 SFMTLDVCTKYTIYGFKGEGIITLtnssLLGGVY-------YTSDSGQLLAFKNVTSgAIYSVTPC-SFSQQAAYVDDdi 74
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  672 ----SSSPALLYRNLKcsyvlnnisfISQPFYFDSYLGCVLNAVNLTSYSVSSCdlrmGSGfCIDYALPSSGGsgsgiss 747
Cdd:cd22376     75 vgviSSLSNSTFNSTR----------ELPGFFYHSNDGSNCTEPVLVYSNIGVC----KSG-SIGYVPSQSGQ------- 132
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  748 pyrfVTFEPfnvsfvndsveTVGGLfeIQIPTNFTIAGHEEFIQTSSPKVTIDCSAFVCSNYAACHDLLSEYGTFCDNIN 827
Cdd:cd22376    133 ----PKIAP-----------MVTGN--ISIPTNFTMSIRTEYLQLYNTPVSVDCAMYVCNGNSRCKQLLTQYTSACKTIE 195
                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  828 SILN--------EVNDLLDITQ--LQVANAlmqgvtlsSNLNTnlhsdvDNIDFKSLLGClgsqcGSSSRSLLEDLLFNK 897
Cdd:cd22376    196 SALQlsarlesvEVNSMLTISEeaLQLATI--------SSFNG------GGYNFTNVLGA-----SVQKRSFIEDLLFNK 256
                          330       340       350       360       370       380       390       400
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  898 VKLSDVGFV-EAYNNCTGGSEIRDLLCVQSFNGIKVLPPILSETQISGYTTAATVAAMFPPWSAAAGVPFSLNVQYRING 976
Cdd:cd22376    257 VVTNGLGTVdEDYKRCSNGLSVADLVCAQYYSGVMVLPGVVDAEKLHMYSASLIGGMVLGGITAAAALPFSYAVQARLNY 336
                          410       420       430       440       450       460       470       480
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  977 LGVTMDVLNKNQKLIANAFNKALLSIQNGFTATNSA--------------LAKIQSVVNANAQALNSLLQQLFNKFGAIS 1042
Cdd:cd22376    337 VALQTDVLQRNQQLLAESFNSAIGNITSAFESVKEAisqtsqglntvahaLTKVQDVVNSQGAALNQLTVQLQHNFQAIS 416
                          490       500       510       520       530       540       550       560
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797 1043 SSLQEILSRLDNLEAQVQIDRLINGRLTALNAYVSQQLSDITLIKAGASRAIEKVNECVKSQSPRINFCGN-GNHILSLV 1121
Cdd:cd22376    417 SSIDDIYSRLDQLSADAQVDRLITGRLSALNAFVAQTLTKYTEVQASRKLAQQKVNECVKSQSQRYGFCGGdGEHIFSLV 496
                          570       580       590       600       610       620       630       640
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797 1122 QNAPYGLLFIHFSYKPTSFKTVLVSPGLCLSGDRGIAPKQGYFIK-------QNDSWMFTGSSYYYPEPISDKNVVFMNS 1194
Cdd:cd22376    497 QAAPQGLLFLHTVLVPGDFVNVTAIAGLCVDDEIALTLREPGVLFthevltyTATEYFVSPRKMFEPRKPTVSDFVQIES 576
                          650       660       670       680       690       700       710
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|...
gi 1002351797 1195 CSVNFTKAPFIYLNNSIPNLSDFEAELSLWFKNhtsiAPNLT---FNSHI-NATFLDLYYEMNVIQESIKSLN 1263
Cdd:cd22376    577 CVVTYVNLTSDQLPDVIPDYIDVNKTLDEILAS----LPNRTgpsLPLDVfNATYLNLTGEIADLEQRSESLR 645
bCoV_S1_N pfam16451
Betacoronavirus-like spike glycoprotein S1, N-terminal; This entry represents the N-terminal ...
28-312 2.68e-75

Betacoronavirus-like spike glycoprotein S1, N-terminal; This entry represents the N-terminal domain of the betacoronavirus-like trimeric spike glycoprotein. The distal S1 subunit of the coronavirus spike protein is responsible for receptor binding. S1 contains two domains; an N-terminal galectin-like domain (NTD) and a receptor-binding domain (S1 RBD) also referred to as the S1 CTD or domain B. Either the S1 NTD or S1 RBD, or occasionally both, are involved in binding to host receptors. S1 NTD is located on the side of the spike trimer and mainly recognizes sugar receptors. For many betacoronaviruses (b-CoVs), for example mouse hepatitis virus (MHV), the RBD is located in the NTD. The structure of the MHV S1 NTD showed the same fold as human galectins (galactose-binding lectin), however it does not bind any sugar; instead, it binds to the carcinoembryonic antigen cell-adhesion molecule CEACAM1) through protein-protein interactions. All three CEACAM21a-binding sites in MHV spikes can be fully occupied by CEACAM1a. It has been shown that CEACAM1a binding to the MHV spike weakens the interactions between S1 and S2 and facilitates the proteolysis of the spike protein and dissociation of S1. The homologous bovine CoV (BCov) S1 NTD also possesses a galectin fold but binds to sialic acid-containing moieties on host cell membranes, as does the NTD of three other group A b-Covs, namely human CoV (HCoV) OC43, avian b-CoV, and infectious bronchitis virus (IBV). Despite the S1 NTD of human respiratory b-CoV HKU1 being highly homologous to the NTDs of MHV and bovine CoV, it does not bind to either sugar or human carcinoembryonic antigen-related cell adhesion molecules (CEACAMs) and the RBD is found instead in the S1 RBD domain.


Pssm-ID: 465119  Cd Length: 296  Bit Score: 251.95  E-value: 2.68e-75
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797   28 DVSLGLGTYYVLNRVYLNTTLLFTGYFPKSGANFRDLALKGSIYLSTLWYKPPFLSdFNNGIFSKVKNTKLYVNNTLYSE 107
Cdd:pfam16451    1 DVSKADGTYYLPDRVYSNTTTLRQGLFPKQGDNVTNYVYSPAHHCGKRNFSTPFLP-FGDGIFVHIGNASNATGGRIISE 79
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  108 FSTIVIGSVFVNTSYTIVVQPHN--GILEITACQYTMCEYPHTVCKSKGS--IRNESWHIDSSEPLCLFKKNFTYNVSAD 183
Cdd:pfam16451   80 PPAFVFGSTFGNTSHTLIIAPDScqTNLTILVCNFTLCANPVTACRWGAGnyNANNSLVYFKNAINCTFNRTYNITFDTS 159
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  184 WLYFHFYQERGVFYAYYA------DVGMPTTFLF-SLYLGTILSHYYVMPLTCNAISSNTdNETLEYWVTPLSRRQYLLN 256
Cdd:pfam16451  160 LIYFGFKQQDGGFHIYYSywlpdlDSGPPTLFPFaTLPLGINITYFQVIPSSIRSTQNCR-RANAAYYVAPLKPSTFLLD 238
                          250       260       270       280       290
                   ....*....|....*....|....*....|....*....|....*....|....*.
gi 1002351797  257 FDEHGVITNAVDCSSSFLSEIQCKTQSFAPNTGVYDLSGFTVKPVATVYRRIPNLP 312
Cdd:pfam16451  239 FDVNGYITNAVDCSFDPLSELKCSTGSFEPDTGVYSTSSYRAQPVGSVYVRQPNVT 294
CoV_Spike_S1_RBD cd21470
receptor-binding domain of the S1 subunit of coronavirus spike (S) proteins; This family ...
298-461 4.69e-63

receptor-binding domain of the S1 subunit of coronavirus spike (S) proteins; This family contains the receptor-binding domain (RBD) of the S1 subunit of coronavirus (CoV) spike (S) proteins from three highly pathogenic human coronaviruses (CoVs), including Middle East respiratory syndrome coronavirus (MERS-CoV), Severe acute respiratory syndrome (SARS) coronavirus (SARS-CoV), and SARS coronavirus 2 (SARS-CoV-2), also known as a 2019 novel coronavirus (2019-nCoV), as well as S proteins from related coronaviruses. The CoV S protein is an envelope glycoprotein that plays the most important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains a hydrophobic fusion peptide and two heptad repeat regions. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-terminal domain (C-domain). Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBD of mouse hepatitis virus (MHV) is located at the NTD, most CoVs, including SARS-CoV-2, SARS-CoV and MERS-CoV use the C-domain to bind their receptors. MHV uses mouse carcinoembryonic antigen related cell adhesion molecule 1a (mCEACAM1a) as the receptor, and the receptors for SARS-CoV and MERS-CoV are human angiotensin-converting enzyme 2 (ACE2) and human dipeptidyl peptidase 4 (DPP4), respectively. Recent studies found that the RBD of SARS-CoV-2 S protein binds strongly to human and bat angiotensin-converting enzyme 2 (ACE2) receptors. Moreover, SARS-CoV-2 RBD exhibited significantly higher binding affinity to the ACE2 receptor than SARS-CoV RBD. Due to the key role of the S protein RBD in viral attachment, it is the major target for antibody-mediated neutralization. This model corresponds to the S1 subunit C-domain that serves as the RBD for most CoVs.


Pssm-ID: 394823  Cd Length: 171  Bit Score: 211.96  E-value: 4.69e-63
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  298 VKPVATVYRRIPNLPDCDIDNWLNNVSVPSPLNWERRIFSNCNFNLSTLLRLVHVDSFSCNNLDKSKIFGSCFNSITVDK 377
Cdd:cd21470      1 VKPSGSVVRRPNNTPLCDFSEWLNATSVPSVYNWERKVFSNCNFNLSKLLSLFSVDSFTCNGISPAKIAGLCFSSITVDK 80
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  378 FAIPNRRRDDLQLGSSGFLQSSNYKIDISSSSCQLYYSLPLVNvtinnfnpsswnrrygfgSFNLSSYDVVYSDHCFSVN 457
Cdd:cd21470     81 FAIPLSRKSDLQPGSAGFIQDYNYKIDFDNTSCQLAYNLPANN------------------ATITKNHDYVYIQKFLGWS 142

                   ....
gi 1002351797  458 SDFC 461
Cdd:cd21470    143 TDGC 146
bCoV_S1_RBD pfam09408
Betacoronavirus spike glycoprotein S1, receptor binding; This entry represents the receptor ...
326-483 1.22e-30

Betacoronavirus spike glycoprotein S1, receptor binding; This entry represents the receptor binding domain (S1 RBD) of the betacoronavirus spike glycoprotein. The spike glycoprotein is arranged in trimers on the surface of the viral membrane and is essential for viral entry. The spike protein is translated as a large polypeptide that is subsequently cleaved to the distal S1, responsible for receptor binding, and the membrane-anchored S2 responsible for membrane fusion. The coronavirus (SARS-CoV) S1 subunit is composed of two distinct domains: an N-terminal domain (S1 NTD) and a receptor-binding domain (S1 RBD) also referred to as the S1 CTD or domain B. Each of these domains have been implicated in binding to host receptors. However, most coronaviruses are not known to utilize both the S1 NTD and S1 RBD for viral entry. SARS-CoV makes use of its S1 RBD to bind to the human angiotensin-converting enzyme 2 (ACE2) as its host receptor.


Pssm-ID: 462789  Cd Length: 156  Bit Score: 118.76  E-value: 1.22e-30
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  326 PSPLNWERRIFSNCNFNLSTLLRLVHVDSFSCNNLDKSKIFGSCFNSITVDKFAIPNRRRDDLQLGSSGFLQSSNYKIDI 405
Cdd:pfam09408    1 PSPANWERKTFSNCNFDFSVLLSLLQVSSFKCYGVSPSKLADMCYGSVTIDYFAIPETHKSNLQPGSPGAISKYNYKLPD 80
                           90       100       110       120       130       140       150
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 1002351797  406 SSSSCQLYYSLP-LVNVTINNFNPSSWNRRYGFGSFNLSSYDVVYSDHCFSVNSDFCPCAdpsVVNSCAKSKPPSAICP 483
Cdd:pfam09408   81 DFYGCVLAFNVNaNTNYAFADNYPYRYIKPGQYQPCNSFVSTVPNSPDGHYCTPSSFNGV---VVITLKPATGSNLVCP 156
MERS-like_CoV_Spike_S1_RBD cd21479
receptor-binding domain of the S1 subunit of the Spike (S) protein from Middle East ...
298-448 9.95e-24

receptor-binding domain of the S1 subunit of the Spike (S) protein from Middle East respiratory syndrome coronavirus; This family contains the receptor-binding domain (RBD) of the S1 subunit of the spike (S) protein from the human coronavirus that causes Middle East Respiratory Syndrome (MERS-CoV) and related coronaviruses from animals. MERS-CoV causes severe pulmonary disease in humans. The CoV S protein is an envelope glycoprotein that plays the most important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains a hydrophobic fusion peptide and two heptad repeat regions. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-terminal domain (C-domain). Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBD of mouse hepatitis virus (MHV) is located at the NTD, most CoVs, including MERS-CoV use the C-domain to bind their receptors. MERS-CoV use human dipeptidyl peptidase 4 (DPP4), also called CD26, as its receptor. It binds DPP4 through the RBD of its S1 subunit and then fuses viral and host membranes through its S2 subunit. Due to the key role of the S protein RBD in viral attachment, it is the major target for antibody-mediated neutralization. This model corresponds to the S1 subunit C-domain that serves as the RBD for most CoVs including MERS-CoV.


Pssm-ID: 394826  Cd Length: 216  Bit Score: 100.93  E-value: 9.95e-24
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  298 VKPVATVYRRiPNLPDCDIDNWLNNVSvPSPLNWERRIFSNCNFNLSTLLRLVHVDSFSCNNLDKSKIFGSCFNSITVDK 377
Cdd:cd21479      1 AKPRGTFIEQ-AEGVECDFSPLLKGTP-PQVYNFKRLVFTNCNYNLTKLLSLFQVDEFSCHQISPSALATGCYSSLTVDY 78
                           90       100       110       120       130       140       150
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|.
gi 1002351797  378 FAIPNRRRDDLQLGSSGFLQSSNYKIDISSSSCQLYYSLPlVNVTINNFNPSSWNRRYGFGSFNLSSYDVV 448
Cdd:cd21479     79 FAYPLSMKSYLQPGSAGPIVQFNYKQDFSNPTCRILATVP-ANLTITKPSNYSYITKCSRLTGDGKNPQYV 148
bat_HKU4-like_Spike_S1_RBD cd21487
receptor-binding domain of the S1 subunit of the Spike (S) protein from Tylonycteris bat ...
309-431 6.46e-21

receptor-binding domain of the S1 subunit of the Spike (S) protein from Tylonycteris bat coronavirus HKU4 and similar proteins; This group contains the receptor-binding domain (RBD) of the S1 subunit of the spike (S) protein from Tylonycteris bat coronavirus HKU4 and other Middle East Respiratory Syndrome (MERS)-related coronaviruses. The CoV S protein is an envelope glycoprotein that plays the most important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains a hydrophobic fusion peptide and two heptad repeat regions. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-terminal domain (C-domain). Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBD of mouse hepatitis virus (MHV) is located at the NTD, most CoVs, including human MERS-CoV that is phylogenetically closely related to bat CoV HKU4 use the C-domain to bind their receptors. HKU4 is able to bind the MERS-CoV receptor, human dipeptidyl peptidase 4 (DPP4), also called CD26. Due to the key role of the S protein RBD in viral attachment, it is the major target for antibody-mediated neutralization. This model corresponds to the S1 subunit C-domain that serves as the RBD for most CoVs including MERS-CoV, and most likely, bat CoV HKU4.


Pssm-ID: 394834  Cd Length: 219  Bit Score: 92.73  E-value: 6.46e-21
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  309 PNLPDCDIDNWLNNVSvPSPLNWERRIFSNCNFNLSTLLRLVHVDSFSCNNLDKSKIFGSCFNSITVDKFAIPNRRRDDL 388
Cdd:cd21487     11 PNATECDFSPMLTGVA-PQVYNFKRLVFSNCNYNLTKLLSLFAVDEFSCNGISPDAIARGCYSTLTVDYFAYPLSMKSYI 89
                           90       100       110       120
                   ....*....|....*....|....*....|....*....|...
gi 1002351797  389 QLGSSGFLQSSNYKIDISSSSCQLYYSLPlVNVTINnfNPSSW 431
Cdd:cd21487     90 RPGSAGNIPLYNYKQSFANPTCRVMASVP-ANVTIT--KPEAY 129
human_MERS-CoV_Spike_S1_RBD cd21486
receptor-binding domain of the S1 subunit of the Spike (S) protein from human Middle East ...
299-417 7.60e-15

receptor-binding domain of the S1 subunit of the Spike (S) protein from human Middle East respiratory syndrome coronavirus; This group contains the receptor-binding domain (RBD) of the S1 subunit of the spike (S) protein from the human coronavirus that causes Middle East Respiratory Syndrome (MERS-CoV). MERS-CoV causes severe pulmonary disease in humans. The CoV S protein is an envelope glycoprotein that plays the most important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains a hydrophobic fusion peptide and two heptad repeat regions. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-terminal domain (C-domain). Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBD of mouse hepatitis virus (MHV) is located at the NTD, most CoVs, including MERS-CoV use the C-domain to bind their receptors. MERS-CoV use human dipeptidyl peptidase 4 (DPP4), also called CD26, as its receptor. It binds DPP4 through the RBD of its S1 subunit and then fuses viral and host membranes through its S2 subunit. Due to the key role of the S protein RBD in viral attachment, it is the major target for antibody-mediated neutralization. This model corresponds to the S1 subunit C-domain that serves as the RBD for most CoVs including MERS-CoV.


Pssm-ID: 394833  Cd Length: 219  Bit Score: 75.17  E-value: 7.60e-15
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  299 KPVATVYRRIPNLpDCDIDNWLNNVSvPSPLNWERRIFSNCNFNLSTLLRLVHVDSFSCNNLDKSKIFGSCFNSITVDKF 378
Cdd:cd21486      2 KPSGSVVEQAEGV-ECDFSPLLSGTP-PQVYNFKRLVFTNCNYNLTKLLSLFSVNDFTCSQISPAAIASNCYSSLILDYF 79
                           90       100       110
                   ....*....|....*....|....*....|....*....
gi 1002351797  379 AIPNRRRDDLQLGSSGFLQSSNYKIDISSSSCQLYYSLP 417
Cdd:cd21486     80 SYPLSMKSDLSVSSAGPISQFNYKQSFSNPTCLILATVP 118
SARS-CoV-like_Spike_S1_NTD cd21624
N-terminal domain of the S1 subunit of the Spike (S) protein from Severe acute respiratory ...
34-281 4.89e-12

N-terminal domain of the S1 subunit of the Spike (S) protein from Severe acute respiratory syndrome coronavirus and related betacoronaviruses in the B lineage; This subfamily contains the N-terminal domain (NTD) of the S1 subunit of the Spike (S) proteins from betacoronaviruses in the sarbecovirus subgenera (B lineage), including the highly pathogenic human coronavirus (CoV), Severe acute respiratory syndrome (SARS) CoV, and SARS-CoV-2, also known as a 2019 novel coronavirus (2019-nCoV) or COVID-19 virus. The CoV S protein is an envelope glycoprotein that plays the most important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains a hydrophobic fusion peptide and two heptad repeat regions. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-terminal domain (C-domain). Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). Most CoVs, including SARS-CoV-2 and SARS-CoV, use the C-domain to bind their receptors. The S1 NTD contributes to the Spike trimer interface.


Pssm-ID: 394950  Cd Length: 280  Bit Score: 68.13  E-value: 4.89e-12
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797   34 GTYYVLNRVYLNTTLLFTGYFPKSGANFRDLALKGSIYLSTLWYKPPFLsDFNNGIFSKVKntklyvnntlySEFSTI-- 111
Cdd:cd21624     23 GVYYPDDIFRSDVLVLTQDYFLPFNSNVTWYHSLNALGERKYYFDNPVL-PFGDGVYFAAT-----------EKSNVVrg 90
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  112 -VIGSVFVNTSYTIVVQPHNGILEITACQYTMCEYPHTVCKSKGSIRN----------------ESWHIDSSEPLCLFKk 174
Cdd:cd21624     91 wIFGSTFDNTSQSAIIVNNGTHIIIRVCNFQLCKNPMFAVSKPGTQTNswiysnafnctyeyvsQSFQLDVSEKNGNFK- 169
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  175 nftynvsaDWLYFHFYQERGVFYAYYA------DVGMPTTF-----LFSLYLGTILSHYYVMPLTCNAISSNTDNETLEY 243
Cdd:cd21624    170 --------HLREFVFKNVDGFLKVYHGyqpinvVRGLPSGFsvlkpIFKLPLGINITNFRVVLTMFSPAQSNWTAGNAAY 241
                          250       260       270
                   ....*....|....*....|....*....|....*...
gi 1002351797  244 WVTPLSRRQYLLNFDEHGVITNAVDCSSSFLSEIQCKT 281
Cdd:cd21624    242 YVGYLKPTTFMLKFDENGTITDAVDCSQDPLAELKCTL 279
CoV_S1_C pfam19209
Coronavirus spike glycoprotein S1, C-terminal; This entry represents a domain found at the ...
604-661 6.13e-12

Coronavirus spike glycoprotein S1, C-terminal; This entry represents a domain found at the C-terminus of the Coronavirus S1 protein. It is found across a range of alpha, beta and gamma coronaviruses. This small all beta stranded domain is known as subdomain 2 in the structure of the porcine epidemic diarrhea virus spike protein.


Pssm-ID: 437047 [Multi-domain]  Cd Length: 57  Bit Score: 61.87  E-value: 6.13e-12
                           10        20        30        40        50
                   ....*....|....*....|....*....|....*....|....*....|....*....
gi 1002351797  604 GVCVNYDLYGITGQGIFKEVSAAYYNnwqNLLY-DSNGNIIGFKDFLTNKTYTILPCYS 661
Cdd:pfam19209    1 NVCTDYTIYGITGTGVIRETNSTIPS---GLYYtSSSGDLLGFKNSTTGTVYSVTPCVS 56
Fibritin_C pfam07921
Fibritin C-terminal region; This family features sequences bearing similarity to the ...
1258-1291 3.40e-08

Fibritin C-terminal region; This family features sequences bearing similarity to the C-terminal portion of the bacteriophage T4 protein fibritin. This protein is responsible for attachment of long tail fibres to virus particle, and forms the 'whiskers' or fibres on the neck of the virion. The region seen in this family contains an N-terminal coiled-coil portion and the C-terminal globular foldon domain (residues 457-486), which is essential for fibritin trimerization and folding. This domain consists of a beta-hairpin; three such hairpins come together in a beta-propeller-like arrangement in the trimer, which is stabilized by hydrogen bonds, salt bridges and hydrophobic interactions.


Pssm-ID: 254516 [Multi-domain]  Cd Length: 93  Bit Score: 52.46  E-value: 3.40e-08
                           10        20        30
                   ....*....|....*....|....*....|....
gi 1002351797 1258 SIKSLNGSGYIPEAPRDGQAYVRKDGEWVLLSTF 1291
Cdd:pfam07921   60 GVQALQESGKIDDAPDDGRWYVRKDGAWVLLSSI 93
MERS-CoV-like_Spike_S1_NTD cd21626
N-terminal domain of the S1 subunit of the Spike (S) protein from Middle East respiratory ...
27-279 3.40e-08

N-terminal domain of the S1 subunit of the Spike (S) protein from Middle East respiratory syndrome-related coronavirus and related betacoronaviruses in the C lineage; This subfamily contains the N-terminal domain (NTD) of the S1 subunit of the Spike (S) proteins from betacoronaviruses in the merbecovirus subgenera (C lineage), including the highly pathogenic human coronavirus (CoV), Middle East respiratory syndrome (MERS)-related CoV, and related bat CoVs. The CoV S protein is an envelope glycoprotein that plays the most important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains a hydrophobic fusion peptide and two heptad repeat regions. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-terminal domain (C-domain). Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). Most CoVs, including MERS-CoV, use the C-domain to bind their receptors. Despite using the C-domain as its receptor, neutralizing antibodies targeting MERS-CoV S1-NTD have been reported, including human antibody CDC2-A2, murine antibodies G2 and 5F9, and macaque antibodies FIB-H1 and JC57-13. G2 has been shown to strongly disrupt the attachment of MERS-CoV S to its receptor, dipeptidyl peptidase-4 (DPP4). In addition, the S1 NTD contributes to the Spike trimer interface.


Pssm-ID: 394952  Cd Length: 328  Bit Score: 56.97  E-value: 3.40e-08
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797   27 VDVSLGLGTYYVLNRVYLNTTLLFTGYFPKSGanfrDLalkGSIYLSTLWYKPP------FLS-------DFNNGIFSKV 93
Cdd:cd21626     26 IDVSKADGVIYPNGRTYSNITLTYTGLFPKQG----DL---GKQYVYSAGHAAPntlnklFVSnyslqvePFDNGFVVRI 98
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797   94 --KNTKLYVNNTLYSEFSTI-------VIGSVFVNTS---------YTIVV----------------QPHNGileiTAC- 138
Cdd:cd21626     99 gaAANKTGTVIISPSTSTTIkkiypafMLGSSVGNFSnnktgryfnHTLVIlpdgcgtllhafycilQPRTG----NRCp 174
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  139 ------QYTMCEYPHTVCKSKGSIRNESWH-IDSSEPL--CLFKKNftYNVSAD----WlyFHFYQE-RGV--FYAYYAD 202
Cdd:cd21626    175 ggssytSYALWDTPATDCSSGNYNRNASLNsFKEYFNLrnCTFFYN--YNITEDeraeW--FGITQDtQGVhlYSSRKGD 250
                          250       260       270       280       290       300       310
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 1002351797  203 VGMPTTFLF-SLYLGTILSHYYVMPLTCNaiSSNTDNETLE-YWVTPLSRRQYLLNFDEHGVITNAVDCSSSFLSEIQC 279
Cdd:cd21626    251 LYGGNMFLFaTLPVYDKIKYYTVIPRSIR--SPQNDRKAWAaFYIYKLHPLTYLLDFDVDGYIRRAIDCGYDDLSQLQC 327
SARS-CoV_Spike_S1_RBD cd21481
receptor-binding domain of the S1 subunit of severe acute respiratory syndrome-related ...
307-467 1.63e-07

receptor-binding domain of the S1 subunit of severe acute respiratory syndrome-related coronavirus Spike (S) protein; This group contains the receptor-binding domain of the S1 subunit of the spike (S) protein from severe acute respiratory syndrome-related coronavirus (SARS-CoV) and similar coronaviruses. The CoV S protein is an envelope glycoprotein that plays the most important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains a hydrophobic fusion peptide and two heptad repeat regions. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-terminal domain (C-domain). Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBD of mouse hepatitis virus (MHV) is located at the NTD, most CoVs, including SARS-CoV use the C-domain to bind their receptors. Due to the key role of the S protein RBD in viral attachment, it is the major target for antibody-mediated neutralization. This model corresponds to the S1 subunit C-domain that serves as the RBD for SARS-CoV and most CoVs.


Pssm-ID: 394828  Cd Length: 222  Bit Score: 53.54  E-value: 1.63e-07
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  307 RIPNLPD-CDIDNWLNNVSVPSPLNWERRIFSNCNFNLSTLLRLVHVDSFSCNNLDKSKIFGSCFNSITVDKFAIPNRRR 385
Cdd:cd21481     10 RFPNITNlCPFGEVFNATKFPSVYAWERKKISNCVADYSVLYNSTFFSTFKCYGVSATKLNDLCFSNVYADSFVVKGDDV 89
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  386 DDLQLGSSGFLQSSNYKIDISSSSCQLYYSLPLVNVT-INNFNPSSWNRRYGfgsfNLSSYDVVYSDHCFSvnSDFCPCA 464
Cdd:cd21481     90 RQIAPGQTGVIADYNYKLPDDFMGCVLAWNTRNIDATsTGNYNYKYRYLRHG----KLRPFERDISNVPFS--PDGKPCT 163

                   ...
gi 1002351797  465 DPS 467
Cdd:cd21481    164 PPA 166
wac PHA02607
fibritin; Provisional
1255-1292 1.72e-06

fibritin; Provisional


Pssm-ID: 177432 [Multi-domain]  Cd Length: 454  Bit Score: 51.95  E-value: 1.72e-06
                           10        20        30        40
                   ....*....|....*....|....*....|....*....|
gi 1002351797 1255 IQESIKSL--NGSGYIPEAPRDGQAYVRKDGEWVLLSTFL 1292
Cdd:PHA02607   412 LKKTVKDLetQIAGKLDDAPSDGSWYVRKNGAWVEVSTGL 451
SARS-CoV-2_Spike_S1_RBD cd21480
receptor-binding domain of the S1 subunit of severe acute respiratory syndrome coronavirus 2 ...
298-415 8.21e-06

receptor-binding domain of the S1 subunit of severe acute respiratory syndrome coronavirus 2 Spike (S) protein; This group contains the receptor-binding domain of the S1 subunit of the spike (S) protein from highly pathogenic human virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), also known as 2019 novel coronavirus (2019-nCoV). The CoV S protein is an envelope glycoprotein that plays the most important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains a hydrophobic fusion peptide and two heptad repeat regions. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-terminal domain (C-domain). Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While RBD of mouse hepatitis virus (MHV) is located at the NTD, most of other CoVs, including SARS-CoV-2 use the C-domain to bind their receptors. Recent studies found that the receptor-binding domain (RBD) of SARS-CoV-2 S protein binds strongly to human and bat angiotensin-converting enzyme 2 (ACE2) receptors. Moreover, SARS-CoV-2 RBD exhibited significantly higher binding affinity to the ACE2 receptor than SARS-CoV RBD. Due to the key role of the S protein RBD in viral attachment, it is the major target for antibody-mediated neutralization. This model corresponds to the S1 subunit C-domain that serves as the RBD for SARS-CoV-2 and most CoVs.


Pssm-ID: 394827  Cd Length: 223  Bit Score: 48.55  E-value: 8.21e-06
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  298 VKPVATVYRrIPNLPD-CDIDNWLNNVSVPSPLNWERRIFSNCNFNLSTLLRLVHVDSFSCNNLDKSKIFGSCFNSITVD 376
Cdd:cd21480      2 VQPTESIVR-FPNITNlCPFGEVFNATRFASVYAWNRKRISNCVADYSVLYNSASFSTFKCYGVSPTKLNDLCFTNVYAD 80
                           90       100       110
                   ....*....|....*....|....*....|....*....
gi 1002351797  377 KFAIPNRRRDDLQLGSSGFLQSSNYKIDISSSSCQLYYS 415
Cdd:cd21480     81 SFVIRGDEVRQIAPGQTGKIADYNYKLPDDFTGCVIAWN 119
SARS-CoV-like_Spike_S1_RBD cd21477
receptor-binding domain of the S1 subunit of severe acute respiratory syndrome-related ...
298-403 1.91e-05

receptor-binding domain of the S1 subunit of severe acute respiratory syndrome-related coronavirus Spike (S) protein and similar proteins; This subfamily contains the receptor-binding domain of the S1 subunit of coronavirus (CoV) spike (S) proteins from highly pathogenic human virus, severe acute respiratory syndrome (SARS) coronavirus (SARS-CoV), SARS coronavirus 2 (SARS-CoV-2), also known as 2019 novel coronavirus (2019-nCoV), and other SARS-like coronaviruses. The CoV S protein is an envelope glycoprotein that plays the most important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains a hydrophobic fusion peptide and two heptad repeat regions. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-terminal domain (C-domain). Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBD of mouse hepatitis virus (MHV) is located at the NTD, most CoVs, including SARS-CoV-2 and SARS-CoV use the C-domain to bind their receptors. Recent studies found that the receptor-binding domain (RBD) of SARS-CoV-2 S protein binds strongly to human and bat angiotensin-converting enzyme 2 (ACE2) receptors. Moreover, SARS-CoV-2 RBD exhibited significantly higher binding affinity to the ACE2 receptor than SARS-CoV RBD. Due to the key role of the S protein RBD in viral attachment, it is the major target for antibody-mediated neutralization. This model corresponds to the S1 subunit C-domain that serves as the RBD for SARS-CoV, SARS-CoV-2, and most CoVs.


Pssm-ID: 394824  Cd Length: 205  Bit Score: 47.12  E-value: 1.91e-05
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  298 VKPVATVYRrIPNLPD-CDIDNWLNNVSVPSPLNWERRIFSNCNFNLSTLLRLVHVDSFSCNNLDKSKIFGSCFNSITVD 376
Cdd:cd21477      2 VSPTTEVVR-FPNITNlCPFDKVFNATRFPSVYAWERTKISDCVADYTVLYNSTSFSTFKCYGVSPSKLIDLCFTSVYAD 80
                           90       100
                   ....*....|....*....|....*..
gi 1002351797  377 KFAIPNRRRDDLQLGSSGFLQSSNYKI 403
Cdd:cd21477     81 TFLIRGSEVRQVAPGQTGVIADYNYKL 107
batCoV-HKU9-like_Spike_S1_NTD cd21627
N-terminal domain of the S1 subunit of the Spike (S) protein from Rousettus bat coronavirus ...
170-279 8.72e-03

N-terminal domain of the S1 subunit of the Spike (S) protein from Rousettus bat coronavirus HKU9 and related betacoronaviruses in the D lineage; This subfamily contains the N-terminal domain (NTD) of the S1 subunit of the Spike (S) proteins from betacoronaviruses in the nobecovirus subgenera (D lineage), including Rousettus bat coronavirus HKU9 and related bat CoVs. The CoV S protein is an envelope glycoprotein that plays the most important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains a hydrophobic fusion peptide and two heptad repeat regions. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-terminal domain (C-domain). Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). Most CoVs, including SARS-CoV-2, SARS-CoV, and MERS-CoV use the C-domain to bind their receptors. However, CoV such as mouse hepatitis virus (MHV) uses the NTD to bind its receptor, mouse carcinoembryonic antigen related cell adhesion molecule 1a (mCEACAM1a). The S1 NTD contributes to the Spike trimer interface.


Pssm-ID: 394953  Cd Length: 289  Bit Score: 39.64  E-value: 8.72e-03
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002351797  170 CLFKKNFTYNVSADWLYFHFYQERGVFYAYYADVG----------MPTTFLFSLYLGTILSHY-----YVMPLTCNAISS 234
Cdd:cd21627    165 CFVNNTFIIPINTSRINLAFRFKDGNLLLYHSAWLptsglnlsgdYPLHYYMSVPVGFNLPNAqffqsVVRPNTEPADGA 244
                           90       100       110       120
                   ....*....|....*....|....*....|....*....|....*
gi 1002351797  235 NTDNeTLEYWVTPLSRRQYLLNFDEHGVITNAVDCSSSFLSEIQC 279
Cdd:cd21627    245 CAAF-QNNLYIAPLSKRELLVSYDDNGSPVNVADCSADAGSELYC 288
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH